ADD CONDITION
Menthol
Last content change checked dailysee data sync status
- Active ingredient
- Menthol 2.7 mg/2850 mg – 5 1/85 g
- Reference brand
- Natural Honey Herb Cough Suppressant Throat Drops
- Dosage forms
- Aerosol, Foam
- Aerosol, Spray
- Chewable Gel
- Cloth
- Cream
- Emulsion
- Gel
- Gel, Dentifrice
- Granule
- Granule, for Solution
- Liniment
- Lipstick
- Liquid
- Liquid, Extended Release
- Lotion
- Lozenge
- Mouthwash
- Oil
- Ointment
- Paste
- Paste, Dentifrice
- Pastille
- Patch
- Patch, Extended Release
- Plaster
- Powder
- Salve
- Soap
- Solution
- Spray
- Stick
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable, Extended Release
- Tablet, Extended Release
- Tablet, Orally Disintegrating
- Tape
- Routes
- Oral
- Respiratory (inhalation)
- Sublingual
- Topical
- Transdermal
- Transmucosal
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1942
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Menthol 2.7 mg/2850 mg – 5 1/85 g
- Reference brand
- Natural Honey Herb Cough Suppressant Throat Drops
- Dosage forms
- Aerosol, Foam
- Aerosol, Spray
- Chewable Gel
- Cloth
- Cream
- Emulsion
- Gel
- Gel, Dentifrice
- Granule
- Granule, for Solution
- Liniment
- Lipstick
- Liquid
- Liquid, Extended Release
- Lotion
- Lozenge
- Mouthwash
- Oil
- Ointment
- Paste
- Paste, Dentifrice
- Pastille
- Patch
- Patch, Extended Release
- Plaster
- Powder
- Salve
- Soap
- Solution
- Spray
- Stick
- Suspension/ Drops
- Syrup
- Tablet
- Tablet, Chewable, Extended Release
- Tablet, Extended Release
- Tablet, Orally Disintegrating
- Tape
- Routes
- Oral
- Respiratory (inhalation)
- Sublingual
- Topical
- Transdermal
- Transmucosal
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1942
- Label revision date
- March 23, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Equate Honey Lemon Cough Drops are lozenges designed to temporarily relieve coughs that may occur with a cold, as well as occasional minor throat irritation and soreness. Similarly, Equate SF Menthol Cough Drops serve the same purpose, providing relief from coughs and throat discomfort. Both products are formulated to soothe your throat and help alleviate the discomfort associated with coughing.
In addition to cough drops, various topical analgesics, such as Biofreeze and Magsoothium, are available in different forms like sprays, gels, and patches. These products are intended for the temporary relief of minor aches and pains in muscles and joints, often associated with conditions like arthritis, backaches, strains, and sprains. They typically contain active ingredients like menthol, which provides a cooling sensation to help ease discomfort.
Uses
You can use this product to temporarily relieve coughs that may occur with a cold, as well as to ease occasional minor irritation and soreness in your throat or mouth. Additionally, it can help alleviate minor aches and pains associated with muscles and joints, including those related to arthritis, backaches, strains, and sprains.
For muscle and joint discomfort, this product is suitable for temporary relief from conditions such as arthritis, simple backaches, and muscle strains. It can also provide soothing relief for sore muscles and joints, helping you feel more comfortable throughout your day.
Dosage and Administration
For adults and children aged 5 years and older, dissolve 1 lozenge slowly in your mouth every 2 hours as needed or as directed by a doctor. If you are a child under 5 years old, please consult a doctor before use.
For topical applications, adults and children aged 2 years and older can apply the product to the affected area not more than 3 to 4 times daily. If you are under 2 years old, consult a doctor before use. Always wash your hands after applying topical products.
For patches, adults and children aged 12 years and older should clean and dry the affected area, then apply the sticky side of the patch. You can wear one patch for up to 8 hours and repeat as necessary, but do not exceed 3 to 4 patches in a day. Children under 12 years should consult a physician before use.
What to Avoid
You should avoid using these products if you have certain conditions or if specific situations arise. Do not use if you are allergic to any ingredient, have open wounds, or damaged skin. It's important to keep these products out of reach of children and to seek medical help if swallowed.
For cough-related products, consult a doctor if your cough persists for more than 7 days, is accompanied by fever, rash, or persistent headache, or if sore mouth symptoms do not improve in 7 days. Additionally, avoid using these products with heating pads or other topical analgesics, and do not bandage tightly. If irritation, pain, or redness develops or worsens, discontinue use and consult a healthcare professional.
Side Effects
If you are using cough drops or topical pain relief products, be aware of the following potential side effects and warnings:
Cough Drops: If you experience a severe sore throat that lasts more than 2 days, or if it is accompanied by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly. These symptoms may indicate a serious condition. Additionally, if your cough persists for more than 7 days or is accompanied by fever or rash, seek medical advice. Sore mouth symptoms should improve within 7 days; if not, consult a dentist or doctor.
Topical Pain Relief Products: These are for external use only. Avoid contact with eyes and do not apply to wounds or damaged skin. If you experience excessive skin irritation, redness, or if your condition worsens or persists for more than 7 days, stop using the product and consult a doctor. Some products may cause a transient burning sensation upon application, which should subside; however, if it becomes severe, discontinue use immediately. Always keep these products out of reach of children, and if ingested, seek medical help right away.
Warnings and Precautions
If you are using any of the products mentioned, please be aware of the following important warnings and precautions:
Sore Throat Warning: If you have a severe sore throat that lasts more than 2 days or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly. These symptoms may indicate a serious condition. If sore mouth symptoms do not improve in 7 days, see your dentist or doctor.
Cough Warning: If your cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache, stop using the product and call your doctor. These could be signs of a serious condition.
General Precautions:
For external use only. Avoid contact with eyes and mucous membranes.
Do not apply to wounds, damaged, or irritated skin.
Do not bandage tightly or use with heating pads or other heating devices.
If you are pregnant or breastfeeding, consult a healthcare professional before use.
Stop Use and Call Your Doctor: If your condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur, discontinue use and consult a doctor.
Emergency Help: If swallowed, get medical help or contact a Poison Control Center immediately.
Always keep these products out of reach of children to prevent accidental ingestion.
Overdose
If you accidentally swallow any of the products listed, it's important to seek medical help or contact a Poison Control Center immediately. Signs of an overdose can vary, but common symptoms may include nausea, vomiting, or unusual behavior. Always keep these products out of reach of children to prevent accidental ingestion.
For specific products, if you experience any adverse effects after swallowing, do not hesitate to reach out for professional assistance. Remember, it's better to be safe and get help if you're unsure about the situation.
Pregnancy Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any of the following products. Many cough drops, topical analgesics, and pain relief gels or creams recommend seeking medical advice due to potential risks that have not been fully evaluated during pregnancy. This includes products like menthol cough drops, pain relief gels, and various topical patches.
While some products do not provide specific information regarding their safety during pregnancy, it is generally advised to err on the side of caution. Always discuss with your healthcare provider to ensure the safety of both you and your baby.
Lactation Use
If you are pregnant or breastfeeding, it is important to consult a healthcare professional before using any medications or products. Many labels indicate that there is a potential for certain substances to be excreted in breast milk, which means they can pass into your breast milk and potentially affect your nursing infant. The effects of these substances on infants are often not well studied, so caution is advised.
For some products, there are no specific warnings or recommendations regarding their use during lactation, but it is still wise to seek guidance from a healthcare provider. Always prioritize your health and the well-being of your baby by discussing any concerns with a professional.
Pediatric Use
When using cough drops and topical pain relief products, it's important to follow specific guidelines for children. For cough drops, if your child is under 5 years old, you should consult a doctor before use. For children aged 5 years and older, they can dissolve one lozenge slowly in their mouth every two hours as needed or as directed by a doctor.
For topical pain relief products, children under 2 years of age should not use these products without consulting a doctor. For children aged 2 years and older, apply the product to the affected area no more than 3 to 4 times daily. Always keep these products out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately. Additionally, some products are not recommended for children under 12 years, especially those with arthritis-like conditions, so consulting a physician is advised in those cases.
Geriatric Use
You may find that many over-the-counter products, such as cough drops and topical pain relief gels, do not provide specific information regarding their use in older adults. This means there are no established dosage adjustments, safety concerns, or special precautions outlined for elderly patients.
When using these products, it's important to monitor for any unusual reactions or side effects, especially if you have underlying health conditions or are taking other medications. If you have concerns or experience any adverse effects, consult your healthcare provider for personalized advice. Always ensure that any product you choose is suitable for your specific health needs.
Renal Impairment
When it comes to medications, it's important to be aware of how kidney health can affect your treatment. For some products, renal impairment may require dosage adjustments, especially if your kidney function is reduced. Regular monitoring of renal function tests is recommended for those with known kidney issues. If your creatinine clearance is less than 30 mL/min, a reduced dose may be necessary to avoid potential toxicity.
Always consult with your healthcare provider before starting any new medication, especially if you have kidney problems, to ensure that your treatment is safe and effective.
Hepatic Impairment
You may be wondering about the safety of using various cough drops and topical pain relief products if you have liver issues. Based on the information available, there are no specific warnings, dosage adjustments, or monitoring requirements related to liver impairment for the products listed. This means that these products do not provide guidance on how to use them safely if you have liver problems.
However, it's always a good idea to consult with your healthcare provider before using any new medication or product, especially if you have existing health conditions. They can provide personalized advice based on your health history and current medications.
Drug Interactions
Most of the cough drops and topical pain relief products listed do not have any reported drug interactions or interactions with laboratory tests. However, it is important to note that some products, like the Cbd Menthol Pain Relief Gel, advise consulting a doctor if you have sensitive skin or are taking blood thinners. Additionally, certain topical analgesics, such as the Healthwise Overnight Menthol Patch, should not be used simultaneously with other topical treatments.
Always discuss your medications and any over-the-counter products with your healthcare provider. This is crucial to ensure safety, avoid potential interactions, and receive personalized advice based on your health history.
Storage and Handling
To ensure the best quality and safety of your products, store them at room temperature (20-25°C or 68-77°F) in a cool, dry place, away from direct sunlight and excessive heat. Keep containers tightly closed when not in use to protect against moisture and light. For cough drops, do not use if the bag is torn or open.
When disposing of any opened products, follow the guidance to discard them after use, especially if they are not used within a specified time frame. Always keep these products out of reach of children, and if you notice any damage to seals or packaging, do not use the product.
Uses and Indications
This drug is indicated for the temporary relief of cough as may occur with a cold, and for the temporary relief of occasional minor irritation and sore throat. It is suitable for adults and children 12 years of age and older, with specific instructions to consult a doctor for children under 12 years.
For the relief of minor aches and pains, this drug is indicated for use in conditions such as arthritis, simple backache, muscle strains, sprains, bruises, and cramps. It provides temporary relief from discomfort associated with these conditions.
Cough Relief
Temporarily relieves cough due to:
Cold
Inhaled irritants
Temporarily relieves occasional minor irritation and pain due to:
Sore throat
Sore mouth
Pain Relief
Temporarily relieves minor aches and pains associated with:
Arthritis
Simple backache
Muscle strains
Sprains
Bruises
Cramps
Limitations of Use
For children under 12 years of age, consult a doctor before use.
Do not exceed the recommended application frequency or duration for patches and topical applications.
This drug does not have any known teratogenic or nonteratogenic effects mentioned in the provided information.
Dosage and Administration
Adults and children 5 years and older are instructed to dissolve 1 lozenge slowly in the mouth, repeating every 2 hours as needed or as directed by a healthcare professional. For children under 5 years, consultation with a doctor is advised.
For topical applications, adults and children 2 years and older should apply the product to the affected area not more than 3 to 4 times daily. Children under 2 years of age should consult a physician before use. Specific instructions include cleaning and drying the affected area prior to application, and in some cases, massaging the product into the skin until fully absorbed.
For patches, adults and children 12 years and older should clean and dry the affected area, apply the sticky side of the patch, and may repeat as necessary, but not more than 3 to 4 times daily. Each patch should not be left on for more than 8 hours, and children under 12 years should consult a physician.
In all cases, if the product comes into contact with hands, it is recommended to wash with soap and water.
Contraindications
Use of these products is contraindicated in the following situations:
Do not apply to wounds, damaged, broken, or irritated skin.
Do not use with heating pads or other heating devices.
Do not bandage tightly.
Avoid contact with eyes and mucous membranes.
Do not use if allergic to any ingredient in the product.
Do not use if pregnant or breastfeeding without consulting a healthcare professional.
Do not use on infants or children under 12 years of age with arthritis-like conditions.
Do not use if you have high blood pressure or are epileptic.
Do not use if excessive skin irritation develops or if symptoms persist for more than 7 days.
Do not use if the product's appearance has changed or if the tamper-evident seal is broken.
Do not use if you have known hypersensitivities to the product or its ingredients.
Do not use if swallowed; seek medical help or contact a Poison Control Center immediately.
Consult a healthcare professional if symptoms worsen or if there are signs of a serious condition, such as persistent cough, fever, rash, or severe sore throat.
Warnings and Precautions
Sore Throat Warnings Severe or persistent sore throat, especially if accompanied by fever, headache, rash, swelling, nausea, or vomiting, may indicate a serious condition. If sore throat persists for more than 2 days, consult a doctor promptly. If sore mouth symptoms do not improve within 7 days, see a dentist or doctor. These symptoms may be serious.
Cough Warnings Consult a doctor if cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
General Precautions
For external use only.
Avoid contact with eyes and mucous membranes.
Do not apply to wounds or damaged skin.
Do not bandage tightly or use with heating pads or devices.
If pregnant or breastfeeding, consult a health professional before use.
Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.
Stop Use and Call Your Doctor
If condition worsens or symptoms persist for more than 7 days.
If redness, irritation, or excessive skin discomfort develops.
If symptoms clear up and occur again within a few days.
If you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied.
Get Emergency Medical Help In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.
Side Effects
Patients using various topical analgesics and cough drops should be aware of potential adverse reactions, which can vary in severity and frequency. The following summarizes the adverse reactions reported across multiple products:
Serious Adverse Reactions
Sore Throat Warning: Severe or persistent sore throat accompanied by high fever, headache, rash, swelling, nausea, or vomiting may indicate a serious condition. Patients should consult a doctor promptly if these symptoms occur. This warning applies to several cough drop products, including those from Equate, Halls, and Freegells.
Skin Reactions: Patients may experience severe skin reactions such as pain, swelling, blistering, or excessive irritation. If these symptoms occur, patients should discontinue use and consult a doctor. This warning is noted for various topical products, including Biofreeze and Dch Cooling Pain Relief.
Common Adverse Reactions
Cough and Sore Throat: If cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache, patients should stop use and consult a doctor. This is a common warning across multiple cough drop labels.
Skin Irritation: Redness, irritation, or pain that persists or worsens after using topical products should prompt patients to stop use and seek medical advice. This is highlighted in warnings for products like Biofreeze, Pain Relief Gel, and various patches.
Additional Considerations
Pregnancy and Breastfeeding: Patients who are pregnant or breastfeeding should consult a healthcare professional before using these products, as some may not be suitable during these periods.
Sensitive Skin: Individuals with sensitive skin should exercise caution and consult a doctor before use, especially if they have a history of allergic reactions to topical treatments.
General Warnings
External Use Only: All products are for external use only and should not be applied to open wounds or damaged skin. Patients should avoid contact with eyes and mucous membranes.
Flammability: Many products are flammable and should be kept away from heat or open flame.
Summary of Stop Use Recommendations
Patients should stop using the product and consult a doctor if:
Symptoms worsen or persist for more than 7 days.
Skin irritation or redness develops.
Severe burning sensation occurs upon application.
This summary provides an overview of the potential adverse reactions associated with topical analgesics and cough drops, emphasizing the importance of monitoring symptoms and consulting healthcare professionals as needed.
Drug Interactions
No specific drug interactions have been reported for the following products across various formulations, including lozenges, gels, creams, sprays, and patches:
Cough Drops: Multiple brands, including Equate, Premier Value, Mgc Health, and others, have no documented drug interactions. This includes various flavors such as honey lemon, menthol, cherry, and sugar-free options.
Topical Analgesics: Products such as Biofreeze, Careall Muscle and Joint Gel, and various pain relief creams and gels report no drug interactions. This category encompasses a wide range of formulations, including sprays, gels, creams, and patches.
Pain Relief Products: Various pain relief formulations, including those from brands like Healthwise, Walgreens, and Gold Bond, have not indicated any drug interactions.
Other Products: Items such as throat lozenges and medicated patches also show no reported drug interactions.
Additionally, some products have specific warnings regarding concurrent use with other topical treatments or medical devices. For instance, the Cold Therapy gel and Pain Relieving Cold Therapy gel advise against combining with other topical treatments or using with medical devices.
Overall, the majority of the products reviewed do not present any known drug interactions, making them generally safe for use without concern for interactions with other medications.
Pediatric Use
Pediatric patients under 5 years of age should consult a doctor before using cough drops, lozenges, or similar products. For children aged 5 years and older, the recommended dosage is to dissolve one lozenge slowly in the mouth every 2 hours as needed or as directed by a healthcare provider.
Age-Specific Recommendations:
Children under 2 years: Consult a doctor before use for any topical products, gels, or sprays.
Children 2 years and older: Many topical products can be applied to the affected area not more than 3 to 4 times daily, but specific instructions should be followed based on the product.
Children under 12 years: Consult a physician before using patches, creams, or gels, especially for conditions like arthritis.
Safety Precautions:
All products should be kept out of reach of children. In case of accidental ingestion, medical help should be sought immediately or contact a Poison Control Center.
For cough drops and lozenges, choking hazards exist for children under 4 years; supervision is advised during use.
General Dosage Information:
Cough Drops/Lozenges:
Children under 5 years: Ask a doctor.
Children 5 years and older: Dissolve 1 lozenge slowly in the mouth; repeat every 2 hours as needed.
Topical Products:
Children under 2 years: Consult a doctor.
Children 2 years and older: Apply to the affected area not more than 3 to 4 times daily.
Special Considerations:
Products intended for children under 12 years with arthritis-like conditions should not be used without consulting a physician.
Pediatric use has not been specifically addressed for some products; healthcare providers should be consulted for guidance.
Geriatric Use
No specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for elderly patients is provided in the inserts for the reviewed products. Therefore, healthcare professionals should exercise caution when administering these products to geriatric patients, as the lack of data may indicate a need for careful monitoring and consideration of individual patient factors. It is advisable to assess the overall health status and potential comorbidities of elderly patients before recommending these products.
Pregnancy
Pregnant patients should consult a healthcare professional before using any of the products listed, as many do not have established safety profiles during pregnancy. The following considerations apply:
General Precautions: For most products, including various cough drops, gels, creams, and patches, it is advised that pregnant or breastfeeding individuals seek medical advice prior to use. This includes products such as menthol cough drops, topical analgesics, and pain relief creams.
Risk to Fetus: Several products have not been evaluated for safety in pregnancy, and potential risks to the fetus cannot be ruled out. For instance, topical analgesics and menthol-containing products may pose unknown risks, and caution is advised.
Contraindications: Some products explicitly state not to use if pregnant or breastfeeding. For example, certain pain relief patches and gels recommend against use during pregnancy due to insufficient safety data.
Dosage Modifications: There are generally no specific dosage modifications provided for pregnant individuals across the various products. It is essential for healthcare providers to assess the risks and benefits on a case-by-case basis.
Special Precautions: Pregnant patients should only use these products if clearly needed and after discussing potential risks with a healthcare provider. This is particularly important for products that have not been studied in pregnant women or lack specific safety information.
In summary, the use of these products during pregnancy should be approached with caution, and healthcare professionals should be consulted to ensure the safety of both the mother and the fetus.
Lactation
Lactating mothers are advised to consult a healthcare professional before using various products, particularly those labeled for cough relief, pain relief, or topical applications. Many products indicate a potential for excretion in breast milk, and the effects on breastfed infants are often not well studied, necessitating caution.
For instance, several cough drops and topical analgesics suggest that nursing mothers should seek medical advice prior to use due to the possibility of excretion in breast milk and the unknown effects on nursing infants. Specific products, such as those from the Premier Value and Mgc Health lines, explicitly state that nursing mothers should consult a doctor, highlighting the need for careful consideration of risks versus benefits.
While some products do not provide specific warnings or recommendations regarding nursing mothers or lactation, it is prudent for lactating mothers to err on the side of caution. The safety of many topical treatments and cough drops during lactation has not been established, and the lack of information regarding excretion in breast milk or associated risks to infants underscores the importance of professional guidance.
In summary, lactating mothers should prioritize consultation with healthcare providers when considering the use of any medication or topical treatment, especially those with potential implications for breast milk and infant health.
Renal Impairment
Patients with renal impairment may require careful consideration when using certain medications. For some products, dosage adjustments may be necessary based on the severity of renal function decline.
Regular monitoring of renal function is recommended for patients with known kidney problems, particularly those with a creatinine clearance of less than 30 mL/min. In such cases, a reduced dose may be warranted to avoid potential toxicity. Special monitoring is advised for patients with significant renal impairment to ensure safety and efficacy.
It is essential for healthcare providers to assess renal function prior to initiating therapy and to conduct regular renal function tests throughout the treatment course. This approach helps to tailor the medication regimen appropriately for patients with compromised kidney function.
Hepatic Impairment
Patients with hepatic impairment may not require specific dosage adjustments, special monitoring, or precautions when using the products listed. The available inserts for these products do not provide any information regarding the effects of hepatic impairment on their pharmacokinetics or safety profiles. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing these products to patients with liver conditions. Regular monitoring of liver function may be advisable, but specific parameters or lab values are not indicated in the product information.
Overdosage
In cases of overdose, it is crucial to seek medical help or contact a Poison Control Center immediately. Symptoms of overdose may vary depending on the specific product ingested, but common recommendations include monitoring for any adverse reactions and providing supportive care as needed.
For products that are ingested accidentally, such as various cough drops, gels, creams, and sprays, immediate medical assistance is advised. Specific products, including Biofreeze, various menthol creams, and pain relief gels, explicitly instruct users to contact a Poison Control Center if swallowed.
In instances where ingestion occurs, it is recommended to keep the affected individual calm and avoid inducing vomiting unless directed by a medical professional. For topical products, if ingested, the same protocol applies: seek medical attention promptly.
Overall, the emphasis is on immediate action and professional guidance in the event of an overdose, as timely intervention can significantly impact outcomes.
Nonclinical Toxicology
Teratogenic Effects
No teratogenic effects were observed in animal studies for the majority of products reviewed. However, specific products indicate that if pregnant or breastfeeding, individuals should consult a health professional before use. This caution is noted for products such as Freegells Cough Drops Menthol Honey Lemon and Cough Drops Dollar General Honey Lemon, among others.
Non-Teratogenic Effects
No significant non-teratogenic effects were reported across the reviewed products. In instances where effects were mentioned, they were not specified in detail.
Nonclinical Toxicology Section
The nonclinical toxicology sections for the majority of products do not provide specific information. For those that do, details are often limited or not applicable.
Animal Pharmacology and Toxicology
Animal studies generally did not show any adverse developmental outcomes or significant pharmacological effects. Notably, products like Ez Massager 2 and Cbd Menthol Pain Relief reported no increase in fetal malformations in animal studies. However, comprehensive pharmacological and toxicological data were not provided for most products, indicating a lack of detailed animal studies or findings.
Storage and Handling
Equate Honey Lemon Cough Drops and Equate Sf Menthol Cough Drops are supplied as lozenges. These products should not be used if the bag is torn or open.
Magsoothium CBD Body is supplied as a spray. It should be stored at room temperature, protected from light, and kept tightly closed. Discard after opening.
Biofreeze and Biofreeze Professional are available in spray and aerosol forms. Biofreeze should be stored in a cool, dry place, away from excessive heat or open flame, and not above 120°F. Biofreeze Professional should be stored at 20-25°C (68-77°F) in a cool, dry place away from direct sunlight.
Saint is supplied as a liquid and should be stored strictly away from light and at low temperatures.
Careall Muscle and Joint is supplied as a gel and should be stored at room temperature, kept out of reach of children, and used for external application only without tight bandaging.
Cannarelief products, including 1000mg and 2000mg salves, should be stored at 68-77°F (20-25°C) and protected from direct sunlight.
Healing Hand Cream 2000mg is supplied as a salve and should be stored at 68-77°F (20-25°C) while avoiding direct sunlight.
Menthol patches, including Kroger Hot and Cold Medicated Patch and Signature Care Medicated Cold and Hot Patch, should be stored at room temperature, not exceeding 86°F (30°C). Reseal the pouch after opening and discard after single use.
Various cough drops, including those from Premier Value, Mgc Health, and others, are supplied as lozenges and should be stored at room temperature, away from excessive heat or sunlight. They should not be used if the bag is torn or open.
Pain relief products, such as Biofreeze, Healthwise Pain Relief, and various gels and creams, should be stored at room temperature, typically between 20-25°C (68-77°F), and kept tightly closed. Many of these products should be protected from light and excessive heat, and some require discarding after opening.
In summary, products should be stored in a cool, dry place, away from direct sunlight and excessive heat, with containers tightly closed. Specific handling instructions include discarding products after opening or if seals are broken.
Product Labels
The table below lists all over-the-counter labels containing menthol. Use it to compare dosage forms, strengths, and uses across products.
More Details | |||||
|---|---|---|---|---|---|
Nantong Health & Beyond Hygienic Products Inc. | Gel | Topical | 25 mg/1 g | 2026 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 25 mg/1 g | 2026 | |
Indications
| |||||
Nantong Health & Beyond Hygienic Products Inc. | Gel | Topical | 4 g/100 g | 2026 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 4 g/100 g | 2026 | |
Indications
| |||||
Nantong Health & Beyond Hygienic Products Inc. | Gel | Topical | 4 g/100 mL | 2026 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 4 g/100 mL | 2026 | |
Indications
| |||||
ARP (USA) Pty Ltd | Cream | Topical | 1.5 g/100 g | 2017 | |
Indications
| |||||
Rinati Skin, LLC | Cream | Topical | 0.1 g/1 mL | 2021 | |
Indications
| |||||
MENPER DISTRIBUTORS INC. | Gel | Topical | 5 mg/100 mL | 2021 | |
Indications
| |||||
Clarion Brands, LLC | Patch | Topical | 5000 mg/1 h | 2018 | |
Indications
| |||||
Clarion Brands LLC. | Patch | Topical | 7500 mg/1 h | 2024 | |
Indications
| |||||
Clarion Brands LLC | Patch | Topical | 7500 mg/1 h | 2024 | |
Indications
| |||||
Clarion Brands, LLC | Patch | Topical | 6500 mg/1 h | 2015 | |
Indications
| |||||
Clarion Brands, LLC | Liquid | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
Clarion Brands, LLC | Liquid | Topical | 4 g/100 mL | 2010 | |
Indications
| |||||
Clarion Brands, LLC | Patch | Topical | 7500 mg/1 h | 2024 | |
Indications
| |||||
Kelada Creative Group LLC DBA SALVE | Cream | Topical | 28 g/90 mL | 2016 | |
Indications
| |||||
EXECUTIVE PRO SOLUTIONS DOO | Gel | Topical | 12 mg/1 mL | 2018 | |
Indications
| |||||
8.0 IDEAL BALANCE D. O. O. BEOGRAD | Cream | Topical | 70 mg/1 mL | 2019 | |
Indications
| |||||
8.0 IDEAL BALANCE D. O. O. BEOGRAD | Gel | Topical | 12 mg/1 mL | 2019 | |
Indications
| |||||
Medline Industries, LP | Gel | Topical | 80 mg/1 mL | 2019 | |
Indications
| |||||
Medline Industries, LP | Spray | Topical | 80 g/1000 g | 2019 | |
Indications
| |||||
Medline Industries, LP | Liquid | Topical | 80 g/1000 g | 2019 | |
Indications
| |||||
Medline Industries, LP | Spray | Topical | 100 mg/1 mL | 2020 | |
Indications
| |||||
Family First Pharmaceuticals, Inc. | Stick | Topical | 0.05138 g/1 g | 2011 | |
Indications
| |||||
Family First Pharmaceuticals, Inc. | Stick | Topical | 0.05138 g/1 g | 2017 | |
Indications
| |||||
INNOVATIONS FOR WELLNESS, LLC | Solution | Topical | 35 mg/1 mL | 2019 | |
Indications
| |||||
Innovations for Wellness, LLC | Cream | Topical | 35 mg/1 mL | 2018 | |
Indications
| |||||
Allure Labs | Cream | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
Allure Labs | Gel | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
Renu Laboratories, Inc. | Liquid | Topical | 1.05 g/84 g | 2020 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2020 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 0.2 g/4 g | 2020 | |
Indications
| |||||
Crosstown Concepts Corporation | Cream | Topical | 5.6 g/112 g | 2020 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2020 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 0.2 g/4 g | 2020 | |
Indications
| |||||
U. S. A. AH LLC | Patch | Topical | 30 mg | 2013 | |
Indications
| |||||
Tianjin Oculax Biotech Inc | Patch | Topical | 2.5 mg/100 mg | 2018 | |
Indications
| |||||
Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
Indiana Botanic Gardens | Ointment | Topical | 0.31 g/100 g | 1995 | |
Indications
| |||||
Amazon | Lozenge | Oral | 5.8 mg | 2026 | |
Indications
| |||||
Amazon. com Services LLC | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
Amazon | Lozenge | Oral | 7.5 mg | 2026 | |
Indications
| |||||
Amish Origins Management, LLC | Spray | Topical | 80 mg/1 mL | 2001 | |
Indications
| |||||
Amish Origins Management, LLC | Cream | Topical | 80 mg/1 g | 2001 | |
Indications
| |||||
Amish Origins Management, LLC | Ointment | Topical | 80 mg/1 g | 2001 | |
Indications
| |||||
COASTAL FORMULAS LLC | Cream | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
COASTAL FORMULAS LLC | Cream | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
Ouwee Jones, LLC | Spray | Topical | 700 mL/1 L | 2011 | |
Indications
| |||||
Safetec of America, Inc. | Spray | Topical | 70 mg/1 L | 2018 | |
Indications
| |||||
Safetec of America, Inc. | Gel | Topical | 70 mg/1 L | 2018 | |
Indications
| |||||
Safetec of America, Inc. | Spray | Topical | 70 mg/1 mL | 2011 | |
Indications
| |||||
ANC Amazon Natural Corp. | Spray | Topical | 5 mL/100 mL | 2011 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
Pharmanuco | Spray | Topical | 5 g/100 mL | 2016 | |
| |||||
Pharmanuco | Spray | Topical | 10 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 3.2 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| |||||
Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| |||||
Pharmanuco | Gel | Topical | 3 g/100 mL | 2017 | |
| |||||
Pharmanuco | Gel | Topical | 3 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 3 g/100 mL | 2016 | |
| |||||
Pharmanuco | Liquid | Topical | 3 g/100 mL | 2016 | |
| |||||
Pharmanuco | Gel | Topical | 2.5 g/100 mL | 2016 | |
| |||||
STRATUS PHARMACEUTICALS INC | Gel | Topical | 3.969 g/113.4 g | 2017 | |
Indications
| |||||
Clinical Resolution Laboratory, Inc. | Cream | Topical | 40 mg/1 g | 2018 | |
Indications
| |||||
WYNNPHARM INC. | Gel | Topical | 30 mg/1 g | 2022 | |
Indications
| |||||
Marketites LLC | Lotion | Topical | 1 g/100 g | 2020 | |
Indications
| |||||
Marketites LLC | Lotion | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Marketites LLC | Lotion | Topical | 1 g/100 g | 2020 | |
Indications
| |||||
Pure Science International, Inc. | Cream | Topical | 5 g/100 g | 2007 | |
Indications
| |||||
RZN Nutraceuticals, Inc. | Cream | Topical | 5 g/100 g | 2007 | |
Indications
| |||||
NDI Solutions LLC | Cream | Topical | 12.5 mg/1 g | 2010 | |
Indications
| |||||
Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
Indications
| |||||
NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 mL | 2017 | |
Indications
| |||||
NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2012 | |
Indications
| |||||
NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2017 | |
Indications
| |||||
NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 g | 2013 | |
Indications
| |||||
NewMarket Health Products LLC | Cream | Topical | 12.5 mg/1 mL | 2017 | |
Indications
| |||||
G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
Indications
| |||||
G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
Indications
| |||||
G2 Products LLC | Cream | Topical | 1.4125 g/113 g | 2020 | |
Indications
| |||||
BIOBEST SERVICES LLC | Cream | Topical | 15 mg/1 mL | 2022 | |
Indications
| |||||
Caribe Natural, Inc | Gel | Topical | 1 g/100 g | 2015 | |
| |||||
World Perfumes, Inc | Gel | Topical | 1 g/100 g | 2015 | |
| |||||
Akron Pharma Inc. | Patch | Topical | 210 mg | 2021 | |
Indications
| |||||
Greenbrier International, Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
Indications
| |||||
Greenbrier International, Inc | Patch | Topical | 5 mg/100 mg | 2014 | |
| |||||
Greenbrier International, Inc. | Patch | Topical | 750 mg | 2013 | |
| |||||
Greenbrier International, Inc. | Gel | Topical | 1.25 g/100 g | 2011 | |
Indications
| |||||
ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 4.54 g/227 g | 2019 | |
Indications
| |||||
ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 4 g/100 g | 2024 | |
Indications
| |||||
ASTONEA LABS PRIVATE LIMITED | Gel | Topical | 5 g/100 g | 2016 | |
Indications
| |||||
BIOCARE LABS INC. | Gel, Dentifrice | Topical | 10 mg/1 g | 2014 | |
Indications
| |||||
NeoPharm Co. , Ltd. | Gel | Topical | 2.5 g/100 g | 2012 | |
Indications
| |||||
NeoPharm Co. , Ltd. | Cream | Topical | 10 g/100 g | 2012 | |
Indications
| |||||
SHENZHEN YUWEN E-COMMERCE CO. , LTD. | Patch | Topical | 470 mg | 2023 | |
Indications
| |||||
SHENZHEN YUWEN E-COMMERCE CO. , LTD. | Solution | Topical | 4 g/100 mL | 2024 | |
Indications
| |||||
ADP Health Limited | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
ADP Health Limited | Cream | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
Unipack, Inc. | Gel | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Unipack LLC | Spray | Topical | 9 g/100 mL | 2014 | |
| |||||
QUALITY CHOICE (Chain Drug Marketing Association) | Patch | Topical | 5 g | 2019 | |
Indications
| |||||
Renu Laboratories, Inc. | Lotion | Topical | 5 g/95 g | 2023 | |
Indications
| |||||
Jonathan International, Inc. | Liniment | Topical | 3.7 g/100 mL | 2015 | |
Indications
| |||||
KTAIGA CO. , LTD. | Gel | Topical | 3 g/120 mL | 2012 | |
Indications
| |||||
Amazon. com | Lozenge | Oral | 5.8 mg | 2021 | |
Indications
| |||||
Amazon. com | Lozenge | Oral | 7.5 mg | 2021 | |
Indications
| |||||
Amazon. com | Lozenge | Oral | 7.6 mg | 2021 | |
Indications
| |||||
Amazon. com | Lozenge | Oral | 5.8 mg | 2021 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Cream | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 1 g/100 g | 2026 | |
Indications
| |||||
SAVE-A-LOT FOOD STORES, LTD. | Patch | Topical | 750 mg | 2013 | |
| |||||
BLOOMWELL GARDENS LLC | Cream | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Patch | Topical | 50 mg | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 25 mg/1 g | 2019 | |
Indications
| |||||
BENOVA RX LLC | Lotion | Topical | 1.1 mg/1 mL | 2025 | |
| |||||
Geritrex LLC | Gel | Topical | 5.085 g/113 g | 2015 | |
| |||||
Geritrex LLC | Spray | Topical | 11.8 g/118 mL | 2015 | |
Indications
| |||||
Bestco LLC | Lozenge | Oral | 5.4 mg | 2022 | |
Indications
| |||||
BioChemics, Inc. | Lotion | Topical | 5.11 g/113 g | 2011 | |
Indications
| |||||
POLIMEROS Y SERVICIOS S. A. | Gel | Topical | 30 mg/1 g | 2019 | |
| |||||
JJindustry. Co. Ltd | Gel | Topical | 4.0 g/100 mL | 2016 | |
Indications
| |||||
JJindustry. Co. Ltd | Gel | Topical | 4.0 g/100 mL | 2016 | |
Indications
| |||||
JJindustry. Co. Ltd | Gel | Topical | 2.1 g/60 mL | 2018 | |
Indications
| |||||
Health Care Laboratories Inc. | Gel | Topical | 0.03 g/1 g | 1998 | |
Indications
| |||||
Health Care Laboratories Inc. | Gel | Topical | 3 g/100 g | 1998 | |
Indications
| |||||
Performance Health, LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2023 | |
Indications
| |||||
RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2024 | |
Indications
| |||||
RB Health (US) LLC | Spray | Topical | 130 mg/1 mL | 2026 | |
Indications
| |||||
RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2014 | |
Indications
| |||||
RB Health (US) LLC | Spray | Topical | 100 mg/1 mL | 2010 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Patch | Topical | 0.05 g/1 g | 2022 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2012 | |
Indications
| |||||
RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2020 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2012 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2013 | |
Indications
| |||||
RB Health (US) LLC | Stick | Topical | 0.15 g/1 g | 2024 | |
Indications
| |||||
RB Health (US) LLC | Patch | Topical | 56 mg/1 g | 2021 | |
Indications
| |||||
RB Health (US) LLC | Liquid | Topical | 70 mg/1 mL | 2020 | |
Indications
| |||||
RB Health (US) LLC | Cream | Topical | 100 mg/1 g | 2021 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
RB Health (US) LLC | Patch | Topical | 0.3 g/6 g | 2022 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
RB Health (US) LLC | Liquid | Topical | 105 mg/1 mL | 2020 | |
Indications
| |||||
RB Health (US) LLC | Aerosol, Spray | Topical | 105 mg/1 mL | 2024 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Spray | Topical | 105 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 50 mg/1 mL | 2016 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 40 mg/1 mL | 2013 | |
Indications
| |||||
Scientific Solutions Global Llc | Liquid | Topical | 10 g/100 mL | 2017 | |
Indications
| |||||
Scientific Solutions Global, LLC | Gel | Topical | 10 g/100 mL | 2017 | |
Indications
| |||||
Scientific Solutions Global, LLC | Cream | Topical | 10 g/100 mL | 2017 | |
Indications
| |||||
Scientific Solutions Global, LLC | Spray | Topical | 10 g/100 mL | 2017 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
Indications
| |||||
Carbon Biotech Llc | Patch | Topical | 0.156 g | 2018 | |
Indications
| |||||
Carbon Biotech Llc | Patch | Topical | 0.348 g | 2018 | |
Indications
| |||||
Floratech Botanicals, LLC | Salve | Topical | 1 g/100 g | 2016 | |
Indications
| |||||
Blistex Inc | Soap | Topical | 1 g/100 mL | 2008 | |
Indications
| |||||
Blistex Inc. | Powder | Topical | 1 g/100 g | 2015 | |
Indications
| |||||
Garcoa, Inc. | Liquid | Topical | 40 mg/1 mL | 2026 | |
Indications
| |||||
Garcoa, Inc. | Gel | Topical | 2.5 mg/1 g | 2025 | |
Indications
| |||||
JMD All Star Impex Inc | Gel | Topical | 2 g/100 g | 2010 | |
Indications
| |||||
JT Cosmetics and Chemicals | Gel | Topical | 2 g/100 g | 2015 | |
Indications
| |||||
Navarro Discount Pharmacies, LLC | Gel | Topical | .02 g/1 g | 2012 | |
Indications
| |||||
Delon Laboratories (1990) Ltd | Gel | Topical | 2 g/100 g | 2010 | |
Indications
| |||||
Select Brand Distributors | Gel | Topical | 2.0 g/100 g | 2014 | |
Indications
| |||||
ACA MANAGEMENT LLC | Cream | Topical | 27.5 mg/1 mL | 2023 | |
Indications
| |||||
ACA MANAGEMENT LLC | Cream | Topical | 14 mg/1 mL | 2025 | |
Indications
| |||||
Budpack Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
Indications
| |||||
Budpak Inc. | Gel | Topical | 0.025 g/1 g | 2012 | |
Indications
| |||||
Jiashen International Trade Limited | Liquid | Topical | 21 mg/1 g | 2025 | |
| |||||
Welly Health PBC | Cream | Topical | 1.5 g/100 g | 2022 | |
Indications
| |||||
Quantum, Inc. | Liquid | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
Sklar BOV Solutions Inc | Spray | Topical | 105 mg/1 g | 2020 | |
Indications
| |||||
Carolina Cannabis Creations LLC | Salve | Topical | 7.9 g/71.9 g | 2023 | |
Indications
| |||||
Earthmed LLC | Salve | Topical | 7.9 g/71.9 g | 2023 | |
Indications
| |||||
New World Imports, Inc | Gel | Topical | 25 mg/1 g | 2012 | |
Indications
| |||||
American Sales Company | Patch | Topical | 0.05 mg | 2019 | |
| |||||
American Sales Company | Patch | Topical | 0.05 mg | 2014 | |
| |||||
FSA STORE INC. | Lozenge | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2025 | |
Indications
| |||||
Aidance Skincare & Topical Solutions, LLC | Oil | Topical | 0.08 kg/1 kg | 2017 | |
Indications
| |||||
Aidance Skincare & Topical Solutions, LLC | Cream | Topical | 4 g/100 g | 2015 | |
Indications
| |||||
Aidance Skincare & Topical Solutions, LLC | Oil | Topical | 8 g/100 mL | 2019 | |
Indications
| |||||
Aidance Skincare & Topical Solutions, LLC | Cream | Topical | 4 g/100 g | 2019 | |
Indications
| |||||
Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
Global Products Group, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
ENDEXX CORPORATION | Cream | Topical | 125 mg/1 mL | 2020 | |
Indications
| |||||
ENDEXX CORPORATION | Cream | Topical | 1.25 g/100 mL | 2019 | |
Indications
| |||||
AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC | Cream | Topical | 40 mg/1 g | 2019 | |
Indications
| |||||
AIDANCE SKINCARE & TOPICAL SOLUTIONS, LLC | Cream | Topical | 40 mg/1 g | 2019 | |
| |||||
Factors Group of Nutritional Products | Cream | Topical | 12.5 mg/1 g | 2012 | |
Indications
| |||||
Natural Factors Nutritional Products Ltd | Cream | Topical | 1.5 g/100 g | 2007 | |
Indications
| |||||
PharmaNutra Usa Corp. | Cream | Topical | 1.4 g/100 g | 2025 | |
Indications
| |||||
Ixxa, Inc. | Patch | Topical | 10 g/100 g | 2024 | |
Indications
| |||||
Tibet Cheezheng Tibetan Medicine Co. Ltd | Cream | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
American Sales | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
HEB | Lozenge | Oral | 5.8 mg | 2013 | |
Indications
| |||||
Safeway Inc. | Lozenge | Oral | 5.8 mg | 2014 | |
Indications
| |||||
The Kroget Co. | Lozenge | Oral | 5.8 mg | 2014 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 5.8 mg | 2013 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 5.8 mg | 2013 | |
Indications
| |||||
Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
Indications
| |||||
Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
Indications
| |||||
Publix | Lozenge | Oral | 5.8 mg | 2018 | |
Indications
| |||||
TopCo Associates | Lozenge | Oral | 5.8 mg | 2013 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
Walmart Stores Inc. | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
Walmart Stores Inc. | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
Winco Foods | Lozenge | Oral | 5.8 mg | 2014 | |
Indications
| |||||
JHK Inc dba American Safety & First Aid | Lozenge | Oral | 7.6 mg | 2000 | |
Indications
| |||||
Saje Natural Business Inc. | Salve | Topical | 27.6 mg/1 g | 2016 | |
| |||||
TIANJIN DARENTANG JINGWANHONG PHARMACEUTICAL CO. , LTD. | Ointment | Topical | 1 g/100 g | 2023 | |
Indications
| |||||
My Import Inc | Gel | Topical | 2 g/100 g | 2010 | |
Indications
| |||||
MDR Fitness Corp. | Gel | Topical | 1 mg/100 mL | 2014 | |
Indications
| |||||
Clean Remedies, LLC | Cream | Topical | 20 mg/1 g | 2019 | |
Indications
| |||||
MAGVERZ INC | Spray | Topical | 16 g/100 mL | 2013 | |
Indications
| |||||
MAGVERZ INC | Cream | Topical | 0.075 g/1 g | 2013 | |
Indications
| |||||
The Mentholatum Company | Patch | Topical | 240–500 mg | 2014 | |
Indications
| |||||
Universal Distribution Center LLC | Patch | Topical | 0.05 g/1 g | 2024 | |
Indications
| |||||
Universal Distribution Center LLC | Patch | Topical | 0.05 g/1 g | 2024 | |
Indications
| |||||
Valu Merchandisers Company, Inc. | Patch | Topical | 875 mg | 2011 | |
Indications
| |||||
Valu Merchandisers Company, Inc. | Patch | Topical | 550 mg | 2022 | |
Indications
| |||||
Valu Merchandisers Company, Inc. | Patch | Topical | 400 mg | 2011 | |
Indications
| |||||
Henan Enokon Medical Instrument Co. , Ltd. | Patch | Topical | 5 g/100 1 | 2026 | |
Indications
| |||||
Henan Enokon Medical Instrument Co. , Ltd. | Patch | Topical | 5 g/100 1 | 2026 | |
Indications
| |||||
CareOne | Liquid | Topical | 16 g/100 mL | 2015 | |
Indications
| |||||
Navarro Discount Pharmacies, LLC | Patch | Topical | 400 mg | 2012 | |
Indications
| |||||
Navarro Discount Pharmacies, LLC | Patch | Topical | 400 mg | 2012 | |
Indications
| |||||
Kareway Product, Inc. | Patch | Topical | 400 mg | 2012 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Patch | Topical | 0.05 g/1 g | 2025 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
InterMed Laboratories Private Limited | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
InterMed Laboratories Private Limited | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
Quality Choice | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
Simple Diagnostics, Inc. | Patch | Topical | 5 g/100 g | 2015 | |
Indications
| |||||
Zhejiang Bangli Medical Products CO. , LTD | Patch | Topical | 5 g/100 g | 2014 | |
Indications
| |||||
Dabur India Limited | Gel | Topical | 4.54 g/227 g | 2019 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 37 mg/1 mL | 2018 | |
Indications
| |||||
AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 mL | 2016 | |
Indications
| |||||
AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 mL | 2016 | |
Indications
| |||||
AHC Ventures Corp DBA Cryoderm | Spray | Topical | 10 g/100 mL | 2016 | |
Indications
| |||||
Kroger | Spray | Topical | 10.5 g/100 g | 2018 | |
Indications
| |||||
Meijer | Gel | Topical | 4 g/100 g | 2018 | |
Indications
| |||||
Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2024 | |
Indications
| |||||
WALGREEN COMPANY | Spray | Topical | 10.5 g/100 g | 2022 | |
Indications
| |||||
Meijer | Spray | Topical | 10.5 g/100 g | 2018 | |
Indications
| |||||
Meijer | Gel | Topical | 4 g/100 g | 2018 | |
Indications
| |||||
Allegiant Health | Gel | Topical | .04 g/1 mL | 2025 | |
Indications
| |||||
SOTAC PHARMACEUTICALS PRIVATE LIMITED | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Yash Pharmaceuticals | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Shopko Stores Operating Co. , LLC | Patch | Topical | 5 g | 2017 | |
Indications
| |||||
Dynarex Corporation | Patch | Topical | 100 mg/5 mg | 2018 | |
Indications
| |||||
PRINCE OF PEACE ENTERPRISES INC. | Granule, for Solution | Oral | 490 mg/5 g | 2010 | |
Indications
| |||||
Envisionate PSJ LLC | Ointment | Topical | 1 g/100 g | 2019 | |
| |||||
PMS4PMS LLC | Cream | Topical | 40 mg/1 g | 2023 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2021 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2023 | |
Indications
| |||||
AMERISOURCE BERGEN | Liquid | Topical | 16 mg/100 mL | 2023 | |
Indications
| |||||
Top Care | Spray | Topical | 16 g/100 g | 2013 | |
Indications
| |||||
Bionpharma Inc. | Liquid | Topical | 16 mg/100 mL | 2022 | |
Indications
| |||||
COOL BREEZE US LLC | Gel | Topical | 51 mg/1 mL | 2023 | |
Indications
| |||||
NeilMed Pharmaceuticals, Inc. | Spray | Topical | 160 mg/1 mL | 2018 | |
Indications
| |||||
Walgreens | Spray | Topical | 160 mg/1 mL | 2013 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
Indications
| |||||
FULL EIGHT Inc | Gel | Topical | 1.2 g/100 mL | 2022 | |
Indications
| |||||
Walgreen Company | Cream | Topical | 4.5 g/100 g | 2025 | |
Indications
| |||||
Walgreens | Gel | Topical | 2.5 g/100 mL | 2016 | |
Indications
| |||||
Tommie Copper, Inc. | Spray | Topical | 16 g/100 g | 2021 | |
Indications
| |||||
United Exchange Corp. | Gel | Topical | .02 g/1 g | 2016 | |
| |||||
United Exchange Corp. | Patch | Topical | 210 mg | 2023 | |
| |||||
United Exchange Corp. | Patch | Topical | 5 mg | 2019 | |
| |||||
United Exchange Corp. | Patch | Topical | 5 mg/1 g | 2013 | |
| |||||
United Exchange Corp. | Patch | Topical | 50 mg/1 g | 2014 | |
| |||||
United Exchange Corp. | Patch | Topical | 336 mg | 2016 | |
| |||||
United Exchange Corp. | Patch | Topical | 336 mg | 2016 | |
| |||||
CVS Pharmacy | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Perrigo Direct Inc. | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Perrigo Direct, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Perrigo Direct, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
Indications
| |||||
The Kroger CO | Pastille | Oral | 5.4 mg | 2022 | |
Indications
| |||||
The Kroger CO | Pastille | Oral | 5.4 mg | 2022 | |
Indications
| |||||
The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
The Kroger CO | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 7.5 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.4 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 7.5 mg | 2022 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 7.6 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
United Natural Foods, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Misero Biotechnology Co, Ltd | Tablet, Orally Disintegrating | Sublingual | 5.4 mg | 2024 | |
Indications
| |||||
Xinsanyang Pharmaceutical (Xiamen) Co. , Ltd. | Tablet, Orally Disintegrating | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Lidl US LLC | Tablet | Oral | 5.8 mg/5.8 mg – 7.5 mg/7.5 mg | 2017 | |
| |||||
Dollar General | Lozenge | Oral | 2.8 mg | 2024 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Melaleuca, Inc. | Lozenge | Oral | 7 mg | 2008 | |
Indications
| |||||
Melaleuca, Inc. | Lozenge | Oral | 7 mg | 2008 | |
Indications
| |||||
Element 26 LLC | Gel | Topical | 100 mg/1 mL | 2023 | |
Indications
| |||||
Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2022 | |
Indications
| |||||
Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2022 | |
Indications
| |||||
Omax Health, Inc | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
Canadian Unique Health Ltd. | Cream | Topical | 12.5 mg/1 g | 2017 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2022 | |
Indications
| |||||
CVS | Spray | Topical | 16 g/100 g | 2022 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 50 mg | 2020 | |
| |||||
CVS Pharmacy | Patch | Topical | 50 mg | 2020 | |
| |||||
CVS PHARMACY, INC. | Patch | Topical | 750 mg | 2010 | |
| |||||
CVS Pharmacy | Liquid | Topical | 16 mg/100 mL | 2021 | |
Indications
| |||||
CVS Pharmacy Inc. | Patch | Topical | 0.05 g/1 g | 2013 | |
| |||||
CVS Pharmacy | Patch | Topical | 0.5 g/10 g | 2025 | |
Indications
| |||||
CVS Pharmacy, Inc | Patch | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 36 mg/1 mL | 2021 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Cream | Topical | 100 mg/1 g | 2021 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 7.5 mg | 2022 | |
Indications
| |||||
CVS Health | Liquid | Topical | 160 mg/1 mL | 2014 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 5.4 mg | 2022 | |
Indications
| |||||
CVS | Spray | Topical | 10.5 g/100 g | 2022 | |
Indications
| |||||
CVS | Gel | Topical | 4 g/100 g | 2020 | |
Indications
| |||||
CVS Pharmacy | Gel | Topical | 40 mg/1 mL | 2026 | |
Indications
| |||||
CVS Pharmacy | Gel | Topical | 50 mg/1 mL | 2026 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 7.6 mg | 2022 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2022 | |
Indications
| |||||
CVS Pharmacy | Lotion | Topical | 1 mg/1 mL | 2010 | |
Indications
| |||||
CVS Pharmacy | Cream | Topical | 0.025 g/1 g | 2008 | |
Indications
| |||||
CVS Pharmacy | Gel | Topical | 2 g/100 g | 2014 | |
Indications
| |||||
CVS Pharmacy | Gel | Topical | 20 mg/1 g | 2010 | |
Indications
| |||||
CVS Pharmacy, Inc. | Patch | Topical | 750 mg | 2013 | |
| |||||
CVS Pharmacy | Gel | Topical | 27.5 mg/1 g | 2011 | |
Indications
| |||||
CVS PHARMACY | Gel | Topical | 2.5 g/100 g | 2014 | |
| |||||
La Mend, Inc. | Patch | Topical | 5 g/100 g | 2021 | |
Indications
| |||||
Garcoa, Inc. | Gel | Topical | 20 mg/1 g | 2017 | |
Indications
| |||||
LaShe Naturals, LLC | Spray | Topical | 60 mg/1 mL | 2008 | |
Indications
| |||||
LaShe Naturals, LLC | Solution | Topical | 60 mg/1 mL | 2011 | |
Indications
| |||||
Derma Care Research Labs, LLC | Spray | Topical | 16 g/100 g | 2021 | |
Indications
| |||||
Derma Care Research Labs, LLC | Spray | Topical | 10.5 g/100 g | 2021 | |
Indications
| |||||
Derma Care Research Labs, LLC | Gel | Topical | 4 g/100 mL | 2022 | |
Indications
| |||||
Derma Care Research Labs, LLC | Liquid | Topical | 16 g/100 g | 2021 | |
Indications
| |||||
Derma Care Research Labs, LLC | Gel | Topical | 2 g/100 g | 2021 | |
Indications
| |||||
DD&D Manufacturing Co. , Ltd | Cream | Topical | 100 mg/1 mL | 2017 | |
Indications
| |||||
doTERRA International, LLC | Stick | Topical | 10 g/100 g | 2022 | |
Indications
| |||||
dōTERRA International, LLC | Stick | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
DOC Brands | Tablet, Extended Release |
| 10 mg | 2026 | |
Indications
| |||||
NFUSE LLC | Emulsion | Topical | 2 g/1 mL | 2024 | |
Indications
| |||||
NFUSE LLC | Emulsion | Topical | 20 g/100 mL | 2024 | |
Indications
| |||||
Private Label Beauty and Wellness | Gel | Topical | 2 g/100 g | 2023 | |
Indications
| |||||
EX Healthcare Inc. | Cream | Topical | 0.5 g/200 mL | 2025 | |
Indications
| |||||
EX Healthcare Inc. | Cream | Topical | 0.1 g/200 mL | 2025 | |
Indications
| |||||
EX Healthcare Inc. | Cream | Topical | 0.4 g/200 mL | 2025 | |
Indications
| |||||
Natures Formulae Health Products Ltd. | Ointment | Topical | 12.7 mg/1 g | 2025 | |
Indications
| |||||
Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2025 | |
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
Dolgencorp Inc | Liquid | Topical | 160 mg/1 mL | 2019 | |
Indications
| |||||
Dolgencorp Inc | Gel | Topical | 40 mg/1 mL | 2020 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Topical | 5.8 mg | 2021 | |
Indications
| |||||
DOLGENCORP INC | Patch | Topical | 750 mg | 2012 | |
| |||||
Dolgencorp Inc | Patch | Topical | 750 mg | 2013 | |
| |||||
DOLGENCORP INC | Patch | Topical | 750 mg | 2013 | |
| |||||
Dolgencorp, LLC | Gel | Topical | 2 g/100 g | 2010 | |
Indications
| |||||
PURIVITAE, LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
PURIVITAE, LLC | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
DISCOUNT DRUG MART | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
DISCOUNT DRUG MART | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
DISCOUNT DRUG MART | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
DISCOUNT DRUG MART | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
DOCTOR'S CHOICE MEDICAL, LLC | Liquid | Topical | 50 mg/1 mL | 2023 | |
Indications
| |||||
Dolgencorp, LLC | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
DOLGENCORP, LLC | Patch | Topical | 5 g | 2017 | |
Indications
| |||||
DOLGENCORP, LLC | Patch | Topical | 5 g/100 g | 2017 | |
Indications
| |||||
DOLGENCORP, LLC | Patch | Topical | 5 g | 2017 | |
Indications
| |||||
Dolgencorp, LLC | Gel | Topical | 4 g/1 mL | 2025 | |
Indications
| |||||
Tai Tong Ah Co Pte Ltd | Oil | Topical | 3.5 g/100 mL | 2004 | |
Indications
| |||||
DR. KHALILI LLC | Cream | Topical | 6 g/100 g | 2025 | |
Indications
| |||||
DOCTOR PAINE'S MEDICAL, LLC | Cream | Topical | 50 mg/1 g | 2020 | |
Indications
| |||||
Dr. Sabharwal's Wound Care | Patch | Topical | 240 mg | 2024 | |
Indications
| |||||
Great Loong LLC | Patch | Topical | 0.5 g/1 g | 2017 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
Indiana Botanic Gardens | Gel | Topical | 4.58 g/100 g | 2016 | |
Indications
| |||||
Indiana Botanic Gardens | Gel | Topical | 3.89 g/100 g | 2003 | |
Indications
| |||||
Carrasco Enterprises, Inc. | Cream | Topical | 40 mg/1 mL | 2015 | |
Indications
| |||||
LTC Health Corp | Cream | Topical | 2.625 g/75 g | 2009 | |
Indications
| |||||
PDC Brands | Cream | Topical | 100 mg/1 g | 2015 | |
Indications
| |||||
PDC Brands | Gel | Topical | 80 mg/1 g | 2018 | |
Indications
| |||||
Genomma Lab USA | Gel | Topical | 40 mg/1 g | 2020 | |
Indications
| |||||
Genomma Lab USA Inc. | Gel | Topical | 4 g/100 g | 2020 | |
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2011 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.5 mg | 2011 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.5 mg | 2011 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2011 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2016 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2011 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2015 | |
Indications
| |||||
Caball Sales, Inc. | Cream | Topical | 1.5 g/100 g | 2024 | |
Indications
| |||||
Caball Sales, Inc. | Spray | Topical | 9 g/100 mL | 2024 | |
Indications
| |||||
Eleeo Brands LLC | Stick | Topical | 0.0425 g/4.25 g | 2025 | |
Indications
| |||||
Earthmed LLC | Salve | Topical | 7.9 g/71.9 g | 2025 | |
Indications
| |||||
Proximity Capital Partners LLC dba Asutra | Cream | Topical | 4 g/100 g | 2019 | |
Indications
| |||||
Easment LLC | Cream | Topical | 1.15 g/115 g | 2026 | |
| |||||
Wicsun Trading | Patch | Topical | 4 g | 2012 | |
Indications
| |||||
Wong’s Pharmaceutical International | Patch | Topical | 4 g | 2012 | |
Indications
| |||||
EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 1000 mg/100 mL | 2013 | |
Indications
| |||||
EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 1700 mg/100 mL | 2013 | |
Indications
| |||||
EMINENCE BIOTECH CORPORATION LIMITED | Spray | Topical | 865.4 mg/50 mL | 2012 | |
Indications
| |||||
Eco Lips, Inc. | Stick | Topical | 0.0425 g/4.25 g | 2023 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2018 | |
Indications
| |||||
EEZAWAY RELIEF INC | Spray | Topical | 1.25 g/100 mL | 2015 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.056 g/1 g | 2022 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2019 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 2.8 g/56 g | 2019 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 2.8 g/56 g | 2019 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 2.8 g/56 g | 2019 | |
Indications
| |||||
Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
Indications
| |||||
Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
Indications
| |||||
Eco-Logics, Inc. | Gel | Topical | 35 mg/1 g | 2016 | |
Indications
| |||||
ACA MANAGEMENT LLC | Cream | Topical | 27.5 mg/1 mL | 2023 | |
Indications
| |||||
Speer Laboratories LLC | Cream | Topical | 2.4 g/120 g | 2023 | |
Indications
| |||||
Speer Laboratories LLC | Cream | Topical | 2.4 g/120 g | 2023 | |
Indications
| |||||
SUPERVALU INC | Gel | Topical | 2 g/100 g | 2011 | |
| |||||
Wal-Mart Stores, Inc. | Gel | Topical | 40 mg/1 mL | 2020 | |
Indications
| |||||
Walmart Inc | Spray | Topical | 105 mg/1 g | 2026 | |
Indications
| |||||
Wal-Mart Stores, Inc. | Gel | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Wal-Mart Stores Inc | Patch | Topical | 50 mg | 2014 | |
Indications
| |||||
Walmart, Inc. | Liquid | Topical | 16 mg/100 mL | 2018 | |
Indications
| |||||
Walmart, Inc. | Liquid | Topical | 16 mg/100 mL | 2020 | |
Indications
| |||||
WalMart | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Walmart | Chewable Gel | Oral | 5 mg | 2024 | |
Indications
| |||||
Walmart | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Wal-Mart Stores Inc | Patch | Topical | 50 mg | 2018 | |
Indications
| |||||
Walmart | Lozenge | Oral | 20 mg | 2024 | |
Indications
| |||||
WalMart | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Prime Enterprises Inc. | Cream | Topical | 12.13 mg/1 mL | 2016 | |
Indications
| |||||
Insight Pharmaceuticals | Ointment | Topical | 9.6 mL/60 mL | 2009 | |
Indications
| |||||
Beiersdorf Inc | Lotion | Topical | 0.1 g/100 mL | 2020 | |
Indications
| |||||
Beiersdorf Inc | Lotion | Topical | 0.1 g/100 mL | 2025 | |
Indications
| |||||
Natural Essentials, Inc. | Gel | Topical | 100 mg/1 g | 2020 | |
Indications
| |||||
Natures Sunshine Products, Inc. | Cream | Topical | 1.25 g/100 mL | 2021 | |
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 7.6 mg | 2025 | |
Indications
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
BLOOMWELL GARDENS LLC | Cream | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
Walgreen Company | Patch | Topical | 5 g/100 g | 2020 | |
Indications
| |||||
Rite Aid Corporation | Patch | Topical | 5 g/100 g | 2021 | |
Indications
| |||||
Cardinal Health, 110 dba LEADER | Patch | Topical | 5 g | 2019 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2019 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2019 | |
Indications
| |||||
Sagely Enterprises Inc. | Cream | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
United Exchange Corp | Patch | Topical | 750 mg | 2014 | |
| |||||
United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| |||||
United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| |||||
United Exchange Corp | Patch | Topical | 750 mg | 2013 | |
| |||||
TROY MANUFACTURING, INC | Liquid | Topical | 80 mg/1 mL | 2010 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2013 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2013 | |
Indications
| |||||
BlackPort Distribution | Gel | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
BlackPort Distribution | Gel | Topical | 4 g/100 mL | 2017 | |
Indications
| |||||
CunningPac | Gel | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
United Exchange Corp. | Gel | Topical | 25 mg/1 g | 2019 | |
| |||||
United Exchange Corporation | Stick | Topical | 20 mg/1 g | 2018 | |
| |||||
FAMILY DOLLAR | Patch | Topical | 750 mg | 2012 | |
| |||||
Family Dollar Services, Inc. | Patch | Topical | 50 mg | 2019 | |
| |||||
Family Dollar | Lozenge | Oral | 7.6 mg | 2025 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
Natural Essentials Inc. | Gel | Topical | 35 mg/1 g | 2013 | |
Indications
| |||||
Natural Essentials Inc. | Spray | Topical | 100 mg/1 mL | 2013 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 33 mg/1 mL | 2021 | |
Indications
| |||||
Natural Essentials, Inc. | Spray | Topical | 89 mg/1 mL | 2021 | |
Indications
| |||||
THE FEEL GOOD LAB, LLC | Cream | Topical | 12.5 mg/1 mL | 2022 | |
Indications
| |||||
The Feel Good Lab | Lotion | Topical | 12.5 mg/1 mL | 2018 | |
Indications
| |||||
The Feel Good Lab | Lotion | Topical | 12.5 mg/1 mL | 2018 | |
Indications
| |||||
THE FEEL GOOD LAB, LLC | Lotion | Topical | 12.5 mg/1 mL | 2020 | |
Indications
| |||||
The Feel Good Lab, LLC | Cream | Topical | 12.5 mg/1 mL | 2021 | |
Indications
| |||||
BeYou Together Ltd | Patch | Topical | 10 mg | 2025 | |
Indications
| |||||
Unexo Life Sciences Private Limited | Patch | Topical | 100 mg | 2024 | |
Indications
| |||||
Unexo Life Sciences, Private Limited | Patch | Topical | 200 mg | 2019 | |
Indications
| |||||
FISICO INC. | Cream | Topical | 50 mg/1 g | 2022 | |
Indications
| |||||
Symedic LLC | Spray | Topical | 2.25 g/100 mL | 2019 | |
Indications
| |||||
SOLVADERM LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Derma Care Research Labs, LLC | Cream | Topical | 1.25 g/100 mL | 2022 | |
Indications
| |||||
PRINCE OF PEACE ENTERPRISES INC. | Granule, for Solution | Oral | 270 mg/6 g | 2010 | |
Indications
| |||||
Catalysis, SL | Cream | Topical | 1.25 mg/1 mL | 2018 | |
Indications
| |||||
Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
Indications
| |||||
New Avon LLC | Lotion | Topical | 13.5 mg/1 mL | 2012 | |
Indications
| |||||
Donegal Bay Ltd | Cream | Topical | 0.1 g/100 mL | 2016 | |
Indications
| |||||
Natures Formulae Health Products Ltd. | Oil | Topical | 24 mg/1 mL | 2016 | |
| |||||
Saje Natural Business Inc. | Oil | Topical | 24 mg/1 mL | 2016 | |
| |||||
McKesson | Lozenge | Oral | 5.8 mg | 2026 | |
Indications
| |||||
McKesson | Lozenge | Oral | 7.5 mg | 2026 | |
Indications
| |||||
McKesson | Lozenge | Oral | 7.6 mg | 2026 | |
Indications
| |||||
WISE CONSUMER PRODUCTS CO. | Oil | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Wise Consumer Products | Lotion | Topical | 1.3 g/100 g | 2024 | |
Indications
| |||||
WISE CONSUMER PRODUCTS CO. | Oil | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Wise Consumer Products | Lotion | Topical | 1.3 g/100 g | 2024 | |
Indications
| |||||
Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2025 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 5.8 mg | 2022 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 5.4 mg | 2022 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 7.5 mg | 2022 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 2.7 mg | 2022 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Suspension/ Drops | Oral | 2.7 mg | 2022 | |
Indications
| |||||
Shandong Vianor Healthy Science Co. , Ltd. | Gel | Topical | 4 g/100 mL | 2020 | |
| |||||
LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 g | 2025 | |
Indications
| |||||
LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 mL | 2025 | |
Indications
| |||||
Natural Essentials, Inc | Spray | Topical | 100 mg/1 g | 2026 | |
Indications
| |||||
Natural Essentials Inc. | Liquid | Topical | 37 mg/1 g | 2023 | |
Indications
| |||||
GASPARI ANTI-AGING LLC | Cream | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Nice-Pak Products, LLC | Gel | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
The Kroger Co. | Gel | Topical | 40 mg/1 mL | 2020 | |
Indications
| |||||
Topco Associates LLC | Gel | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 9 mg | 2021 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 8.4 mg | 2021 | |
Indications
| |||||
Riclan S. A. | Lozenge | Oral | 7 mg | 2021 | |
Indications
| |||||
Geri-Gentle Corporation | Patch | Topical | 50 mg/1 mL | 2022 | |
Indications
| |||||
Geri-Gentle Corporation | Patch | Topical | 50 mg/1 mL | 2022 | |
Indications
| |||||
Germa Products, LLC | Ointment | Topical | 10 mg/1 mL | 2019 | |
| |||||
Germa Products, LLC | Ointment | Topical | 18 mg/1 mL | 2019 | |
| |||||
Chattem, Inc. | Lotion | Topical | 0.005 g/1 g | 2016 | |
Indications
| |||||
Gold Bond Co LLC | Lotion | Topical | 0.005 g/1 g | 2016 | |
Indications
| |||||
Chattem, Inc. | Powder | Topical | 0.8 g/100 g | 2021 | |
Indications
| |||||
Gold Bond Co LLC | Powder | Topical | 0.8 g/100 g | 2021 | |
Indications
| |||||
Chattem, Inc. | Powder | Topical | 1 g/100 g | 2021 | |
Indications
| |||||
Gold Bond Co LLC | Powder | Topical | 1 g/100 g | 2021 | |
Indications
| |||||
Chattem, Inc. | Powder | Topical | 0.15 g/100 g | 2021 | |
Indications
| |||||
Gold Bond Co LLC | Powder | Topical | 0.15 g/100 g | 2021 | |
Indications
| |||||
Eden's Answers, Inc. | Cream | Topical | 62.5 mg/1 mL | 2020 | |
Indications
| |||||
Amerisource Bergen | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
AmerisourceBergen Drug Corporation | Gel | Topical | 2 g/100 g | 1988 | |
Indications
| |||||
Amerisource Bergen | Gel | Topical | 4 g/1 mL | 2025 | |
Indications
| |||||
Geiss, Destin, Dunn | Lozenge | Oral | 5.8 mg | 2021 | |
Indications
| |||||
Geiss, Destin, Dunn | Lozenge | Oral | 7.5 mg | 2021 | |
Indications
| |||||
GOOD SENSE | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Geiss, Destin, Dunn | Lozenge | Oral | 7.6 mg | 2022 | |
Indications
| |||||
Geiss, Destin & Dunn, Inc | Gel | Topical | 4 g/100 mL | 2025 | |
| |||||
Geiss, Destin and Dunn, Inc. | Patch | Topical | 750 mg | 2013 | |
| |||||
Geiss, Destin and Dunn, Inc. | Patch | Topical | 50 mg | 2018 | |
| |||||
Geiss, Destin, Dunn | Lozenge | Oral | 5.4 mg | 2021 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 20 mg/500 mg | 2016 | |
| |||||
Green Compass, Inc. | Gel | Topical | 5 g/100 mL | 2023 | |
Indications
| |||||
Green Compass, Inc. | Liquid | Topical | 5 g/100 mL | 2020 | |
Indications
| |||||
Unifirst First Aid Corporation | Lozenge | Oral | 7.6 mg | 2011 | |
Indications
| |||||
Unifirst First Aid Corporation | Lozenge | Oral | 8.6 mg | 2019 | |
Indications
| |||||
GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
Indications
| |||||
Guangzhou Yilong Cosmetics Co. , Ltd | Granule | Topical | 1.45 g/100 g | 2024 | |
| |||||
Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2024 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 8.8 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2025 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 7.6 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 18 mg | 2025 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2020 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 3.2 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 1.8 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.7 mg | 2020 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 7.5 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 6.8 mg | 2016 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 5.8 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.5 mg | 2021 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.7 mg | 2019 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 2.9 mg | 2020 | |
Indications
| |||||
Mondelez Global LLC | Lozenge | Oral | 5.4 mg | 2019 | |
Indications
| |||||
Mondelēz Global LLC | Lozenge | Oral | 6.4 mg | 2025 | |
Indications
| |||||
Mondelēz Global LLC | Lozenge | Oral | 6.4 mg | 2019 | |
Indications
| |||||
PRINCE OF PEACE ENTERPRISES INC. | Syrup | Oral | 0.1 g/100 mL | 2014 | |
Indications
| |||||
Globalworkscompany. Co. , Ltd. | Gel | Topical | 2.0 g/100 mL | 2020 | |
Indications
| |||||
Harris Teeter | Lozenge | Oral | 5.8 mg | 2026 | |
Indications
| |||||
Harris Teeter | Lozenge | Oral | 7.5 mg | 2026 | |
Indications
| |||||
Harris Teeter | Lozenge | Oral | 5.4 mg | 2026 | |
Indications
| |||||
Harris Teeter | Lozenge | Oral | 7.6 mg | 2026 | |
Indications
| |||||
PALM ORTHOPEDICS & INTERVENTIONAL PAIN LLC | Gel | Topical | 30 mg/1 mL | 2024 | |
Indications
| |||||
Carolina Cannabis Creations LLC | Salve | Topical | 1.4 g/111.45 g | 2023 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 2.18 g/112 g | 2024 | |
Indications
| |||||
Renu Laboratories, LLC | Cream | Topical | 8.74 g/448 g | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
McKesson | Patch | Topical | 428.5 mg | 2017 | |
| |||||
Railroad Sock LLC | Cloth | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 10.5 mg/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 10.5 mg/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g | 2024 | |
Indications
| |||||
Veridian Healthcare | Powder | Topical | 0.8 g/100 g | 2024 | |
Indications
| |||||
Veridian Healthcare | Powder | Topical | 1 g/100 g | 2024 | |
Indications
| |||||
Veridian Healthcare | Powder | Topical | 0.15 g/100 g | 2024 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 10 g/100 g | 2022 | |
Indications
| |||||
Veridian Healthcare | Liquid | Topical | 4 g/1 mL | 2024 | |
Indications
| |||||
Veridian Healthcare | Liquid | Topical | 0.16 g/1 mL | 2024 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 16 g/100 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g | 2025 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 10.5 mg/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Cream | Topical | 10 g/100 g | 2026 | |
Indications
| |||||
Veridian Healthcare | Cream | Topical | 10 g/100 g | 2026 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 2 g/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 0.6 g/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2022 | |
Indications
| |||||
HEB | Lozenge | Oral | 5.8 mg | 2021 | |
Indications
| |||||
HEB | Lozenge | Oral | 7.5 mg | 2021 | |
Indications
| |||||
Davion, Inc | Powder | Topical | 0.15 g/100 g | 2018 | |
Indications
| |||||
HEB | Lozenge | Oral | 5.4 mg | 2021 | |
Indications
| |||||
HEB | Lozenge | Oral | 7.6 mg | 2021 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 0.04 g/1 mL | 2025 | |
Indications
| |||||
Nexxus Capital LLC | Cream | Topical | 3 g/100 g | 2026 | |
Indications
| |||||
Clientele, Inc. | Cream | Topical | 2 mg/100 mL | 2019 | |
Indications
| |||||
Pedicis Research, LLC | Cream | Topical | 50 mg/1 g | 2023 | |
Indications
| |||||
Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2019 | |
Indications
| |||||
Telebrands Corp | Patch | Topical | 5 g/100 g | 2019 | |
Indications
| |||||
Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2020 | |
Indications
| |||||
Telebrands Corp | Gel | Topical | 8 mg/100 mL | 2025 | |
Indications
| |||||
Telebrands Corp | Gel | Topical | 8 g/8 g | 2024 | |
Indications
| |||||
Balassa Laboratories Inc. | Stick | Topical | 0.1 g/1 g | 2021 | |
Indications
| |||||
Meijer, Inc. | Pastille | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 4.8 mg | 2025 | |
Indications
| |||||
WHOLE FOODS MARKET, INC. | Pastille | Oral | 4.8 mg | 2024 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Spray | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
Renu Laboratories, Inc. | Liquid | Topical | 4.2 g/84 g | 2020 | |
Indications
| |||||
Meijer, Inc. | Pastille | Oral | 1.1 mg | 2025 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 1.1 mg | 2025 | |
Indications
| |||||
Bordoloi Biotech, LLC. | Cream | Topical | 70 mg/1 g | 2021 | |
Indications
| |||||
Menper Distributors, Inc. | Gel | Topical | 1 g/100 g | 2012 | |
Indications
| |||||
SIBORG LLC | Cream | Topical | 12.5 mg/1 mL | 2020 | |
Indications
| |||||
HEB | Lozenge | Oral | 7.5 mg | 2013 | |
Indications
| |||||
The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
Indications
| |||||
The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
Indications
| |||||
The Kroger Co. | Lozenge | Oral | 7.5 mg | 2014 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 7.5 mg | 2016 | |
Indications
| |||||
Walgreens Co, | Lozenge | Oral | 7.5 mg | 2016 | |
Indications
| |||||
American Sales | Lozenge | Oral | 7.5 mg | 2016 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 7.5 mg | 2018 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 7.5 mg | 2018 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 7.6 mg | 2019 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 7.5 mg | 2013 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 7.5 mg | 2013 | |
Indications
| |||||
Meijer | Lozenge | Oral | 7.5 mg | 2017 | |
Indications
| |||||
Meijer | Lozenge | Oral | 7.5 mg | 2017 | |
Indications
| |||||
Publix | Lozenge | Oral | 7.5 mg | 2018 | |
Indications
| |||||
Topco Associates | Lozenge | Oral | 7.5 mg | 2013 | |
Indications
| |||||
Trader Joe's Company | Lozenge | Oral | 6 mg | 2018 | |
Indications
| |||||
Walmart Stores Inc. | Lozenge | Oral | 7.5 mg | 2016 | |
Indications
| |||||
Winco foods | Lozenge | Oral | 7.5 mg | 2016 | |
Indications
| |||||
Winco Foods | Lozenge | Oral | 7.5 mg | 2014 | |
Indications
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 7.5 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2024 | |
Indications
| |||||
WHOLE FOODS MARKET, INC. | Pastille | Oral | 7.5 mg | 2024 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Chain Drug Consortium, LLC | Patch | Topical | 5 g/100 g | 2017 | |
Indications
| |||||
Harris Teeter | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Walgreen Company | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Henan Enokon Medical Instrument Co. , Ltd. | Patch | Topical | 5 g/100 1 | 2024 | |
Indications
| |||||
Dynarex | Patch | Topical | 285 mg/5700 mg | 2019 | |
Indications
| |||||
Humco Holding Group, Inc | Liquid | Topical | 16 mg/100 mL | 2018 | |
Indications
| |||||
Humphreys Pharmacal, Incorporated | Liquid | Topical | 12.5 mg/1 mL | 1972 | |
Indications
| |||||
HY-VEE, INC | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
HY-VEE, INC | Lozenge | Oral | 7.5 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2025 | |
Indications
| |||||
HY-VEE, INC | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
HY-VEE, INC | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Filo America | Gel | Topical | 1.0 g/100 g | 2015 | |
Indications
| |||||
China Ningbo Shangge Cosmetic Technology Corp. | Gel | Topical | 1 g/100 g | 2015 | |
| |||||
North & South Wholesalers LLC | Gel | Topical | 1.25 g/100 g | 2018 | |
Indications
| |||||
Personal Care Products | Gel | Topical | 2.27 g/227 g | 2011 | |
Indications
| |||||
Volume Distributors, Inc. | Gel | Topical | 1 g/100 g | 2015 | |
| |||||
China Ningbo Shangge Cosmetic Technology Corp. | Gel | Topical | 2.84 mg/227 mg | 2013 | |
| |||||
Greenbrier International, Inc. | Gel | Topical | 2.84 mg/227 mg | 2013 | |
| |||||
Jell Pharmaceuticals Pvt Ltd | Gel | Topical | 1.25 g/100 g | 2018 | |
Indications
| |||||
Southern Sales & Service, Inc. | Gel | Topical | 0.02 g/1 g | 2015 | |
Indications
| |||||
Gadal Laboratories Inc | Gel | Topical | 2 g/100 g | 2013 | |
Indications
| |||||
Gadal Laboratories, Inc. | Gel | Topical | 16.95 g/113 g | 2012 | |
Indications
| |||||
Southern Sales & Service, Inc. | Gel | Topical | 0.15 g/1 g | 2015 | |
Indications
| |||||
Southern Sales & Service, Inc. | Gel | Topical | 0.02 g/1 g | 2017 | |
Indications
| |||||
Southern Sales & Service, Inc. | Patch | Topical | 5 g/100 g | 2019 | |
Indications
| |||||
Southern Sales & Service, Inc. | Cloth | Topical | 50 mg/1 g | 2022 | |
Indications
| |||||
C. D. M. A. Inc. | Gel | Topical | 55 mg/1 mL | 2013 | |
Indications
| |||||
C. D. M. A. Inc. | Gel | Topical | 55 mg/1 mL | 2013 | |
Indications
| |||||
Natural Essentials, Inc. | Spray | Topical | 100 mg/1 mL | 2020 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 35 mg/1 mL | 2017 | |
Indications
| |||||
Nichiban Company Limited | Patch | Topical | 787.5–866.25 mg | 2009 | |
Indications
| |||||
Chattem, Inc. | Spray | Topical | 16 g/100 g | 2020 | |
Indications
| |||||
Chattem, Inc. | Liquid | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Chattem, Inc. | Liquid | Topical | 0.16 g/1 mL | 2009 | |
Indications
| |||||
Chattem, Inc. | Liquid | Topical | 8 g/100 mL | 2025 | |
Indications
| |||||
Chattem, Inc. | Gel | Topical | 0.025 g/1 g | 2007 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
Indications
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
Indications
| |||||
Adaptive Health, LLC | Cream | Topical | 12.5 mg/1 g | 2019 | |
Indications
| |||||
Healthy Directions, LLC | Cream | Topical | 12.5 mg/1 g | 2019 | |
Indications
| |||||
Healthy Directions, LLC | Liquid | Topical | 12.5 mg/1 g | 2019 | |
Indications
| |||||
WYNNPHARM INC. | Gel | Topical | 30 mg/1 g | 2022 | |
Indications
| |||||
Excel Health, Inc | Gel | Topical | 60 mg/1 mL | 2019 | |
Indications
| |||||
JACK BLACK LLC | Cream | Topical | 2.2 g/100 g | 2019 | |
Indications
| |||||
Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
| |||||
Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
Indications
| |||||
Jakemans (Confectioners) Limited | Lozenge | Oral | 5 mg | 2011 | |
Indications
| |||||
Jakemans (Confectioners) Ltd. | Lozenge | Oral | 5 mg | 2013 | |
Indications
| |||||
BioZone Laboratories, Inc. | Cream | Topical | 50 mg/1 g | 2009 | |
Indications
| |||||
Shaklee Corporation | Cream | Topical | 50 mg/1 g | 2020 | |
Indications
| |||||
Allure Labs | Cream | Topical | 1.5 g/100 g | 2022 | |
Indications
| |||||
Smart Cookie Solutions Inc. | Cream | Topical | 37 mg/1 mL | 2025 | |
Indications
| |||||
Smart Cookie Solutions | Cream | Topical | 100 mg/1 mL | 2025 | |
Indications
| |||||
Smith Amish, LLC | Cream | Topical | 1.25 g/100 g | 2024 | |
Indications
| |||||
Lifeline Naturals of America, Inc. | Ointment | Topical | 16 g/100 mL | 2023 | |
Indications
| |||||
Joy Organics Llc | Cream | Topical | 4 g/100 mL | 2021 | |
Indications
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 1.4 g/28 g | 2021 | |
Indications
| |||||
Just Brands LLC | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
Just Brands LLC | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
Just Brands LLC | Gel | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 1.4 g/28 g | 2021 | |
Indications
| |||||
K19 LLC | Liquid | Topical | 12.5 mg/1 mL | 2023 | |
Indications
| |||||
The Podiatree Co | Liquid | Topical | 10 g/100 mL | 2014 | |
Indications
| |||||
The Podiatree Co | Liquid | Topical | 10 g/100 mL | 2014 | |
Indications
| |||||
Eezaway Relief Inc | Liquid | Topical | 2.75 g/100 mL | 2024 | |
Indications
| |||||
Avlon Industries, Inc. | Gel | Topical | 10 mg/1 g | 2014 | |
Indications
| |||||
No Reason, LLC | Cream | Topical | 100 mg/1 mL | 2020 | |
Indications
| |||||
Fuzhou Ayimong Trading Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2023 | |
Indications
| |||||
Pharmadel LLC | Ointment | Topical | 1.25 g/100 g | 2023 | |
Indications
| |||||
Dee Cee Laboratories, Inc. | Gel | Topical | 2.5 g/100 g | 2012 | |
Indications
| |||||
Kroger | Lozenge | Oral | 5.8 mg | 2020 | |
Indications
| |||||
Kroger Company | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2021 | |
Indications
| |||||
Henan Lingrui Pharmaceutical Co Ltd | Plaster | Transdermal | 3.0 g/100 g | 2010 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 0.8 mg/50 mL | 2016 | |
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 0.8 mg/50 mL | 2016 | |
| |||||
LactiGo, Inc. | Gel | Topical | 12.5 mg/1 mL | 2019 | |
Indications
| |||||
Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Gel | Topical | 0.04 g/1 g | 2022 | |
Indications
| |||||
Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Gel | Topical | 0.04 g/1 g | 2022 | |
Indications
| |||||
Jiangsu Chaben Medical Healthcare Technology Co. , Ltd | Patch | Topical | 0.05 g/1 g | 2022 | |
Indications
| |||||
Lansinoh Laboratories Inc | Cream | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
Young Living Essential Oils, LC | Spray | Topical | 0.005 g/1 g | 2017 | |
Indications
| |||||
Cardinal Health, 110 dba LEADER | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
Cardinal Health 110, LLC. DBA Leader | Lozenge | Oral | 2.5 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2024 | |
Indications
| |||||
Cardinal Health, 110 dba LEADER | Gel | Topical | 20 mg/1 g | 2017 | |
Indications
| |||||
Cardinal Health, 110 dba LEADER | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 1.1 mg | 2024 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 1.1 mg | 2023 | |
Indications
| |||||
Guangdong Aimu Biological Technology Co. , Ltd | Cream | Topical | 7 g/100 g | 2025 | |
Indications
| |||||
Clinical Resolution Laboratory, Inc. | Cream | Topical | 40 mg/1 g | 2019 | |
Indications
| |||||
Ebanel Laboratories, Inc | Cream | Topical | 40 mg/1 g | 2025 | |
Indications
| |||||
Lilas Wellness, Inc. | Patch | Topical | 200 mg | 2019 | |
Indications
| |||||
Lilas Wellness, Inc. | Patch | Topical | 200 mg | 2025 | |
Indications
| |||||
Dengfeng City Jucai Trading Co. , LTD | Patch | Topical | 4 g/100 1 | 2023 | |
| |||||
Quantum, Inc. | Ointment | Topical | 1 mg/1 g | 1984 | |
Indications
| |||||
Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Powder | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Ozeion LLC | Gel | Topical | 0.24 mg/1 mL | 2018 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Cream | Topical | 4 g/100 mL | 2023 | |
Indications
| |||||
Pacific Health Collabroative | Gel | Topical | 2.5 g/100 g | 2013 | |
Indications
| |||||
RENU LABORATORIES, LLC | Cream | Topical | 22.7 g/454 g | 2019 | |
Indications
| |||||
RENU LABORATORIES, LLC | Liquid | Topical | 4.2 g/84 g | 2025 | |
| |||||
RENU LABORATORIES, LLC | Cream | Topical | 5.6 g/112 g | 2019 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2018 | |
Indications
| |||||
RENU LABORATORIES, INC. | Cream | Topical | 5.6 g/112 g | 2019 | |
Indications
| |||||
Ubu/Elements, Inc. | Cream | Topical | 5 g/100 mL | 2023 | |
| |||||
Ubu/Elements, Inc. | Spray | Topical | 118 g/100 mL | 2023 | |
| |||||
Ubu/Elements, Inc. | Cream | Topical | 5 g/100 mL | 2023 | |
| |||||
Ubu/Elements, Inc. | Liquid | Topical | 5 g/100 mL | 2019 | |
| |||||
Cherry Hill Sales Co | Gel | Topical | 2.5 g/100 g | 2014 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Lotion | Topical | 3 g/100 g | 2013 | |
Indications
| |||||
Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
Indications
| |||||
Walmart Stores Inc | Powder | Topical | 0.1 g/1 g | 2020 | |
Indications
| |||||
L'Oreal USA Products Inc | Lipstick | Topical | 5 mg/1 g | 2013 | |
Indications
| |||||
L'Oreal USA Products Inc | Lipstick | Topical | 5 mg/1 g | 2016 | |
Indications
| |||||
McKesson Medical-Surgical | Lozenge | Oral | 7.6 mg | 2022 | |
Indications
| |||||
McKesson Medical-Surgical | Lozenge | Oral | 5.8 mg | 2022 | |
Indications
| |||||
SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
MEDKO LLC | Liquid | Topical | 120 mg/1 mL | 2024 | |
Indications
| |||||
Unifirst First Aid Corporation | Lozenge | Oral | 7.6 mg | 2008 | |
Indications
| |||||
Unifirst First Aid Corporation | Lozenge | Oral | 8.6 mg | 2019 | |
Indications
| |||||
Straight Arrow Products, Inc. | Gel | Topical | .07 g/1 g | 2004 | |
Indications
| |||||
Walmart Stores Inc | Powder | Topical | 0.42 g/283 g | 2020 | |
Indications
| |||||
Walmart Stores Inc | Powder | Topical | 2.26 g/283 g | 2020 | |
Indications
| |||||
Earth Mama Angel Baby LLC | Stick | Topical | 0.0425 g/4.25 g | 2024 | |
Indications
| |||||
Burt's Bees, Inc. | Stick | Topical | 0.9 g/100 g | 2016 | |
Indications
| |||||
American Sales Company | Patch | Topical | 428.5 mg | 2011 | |
Indications
| |||||
Kareway Product, Inc. | Patch | Topical | 428.5 mg | 2011 | |
Indications
| |||||
Kareway Product, Inc. | Patch | Topical | 400 mg | 2011 | |
Indications
| |||||
Unifirst First Aid Corporation | Lozenge | Oral | 5.8 mg | 2011 | |
Indications
| |||||
SHIELD LINE LLC | Gel | Topical | 4.54 g/227 g | 2019 | |
Indications
| |||||
Respect Manufacturing Corporation | Cream | Topical | 2.012 g/50.3 g | 2020 | |
Indications
| |||||
Respect Manufacturing Corporation | Cream | Topical | 2.012 g/50.3 g | 2020 | |
Indications
| |||||
Respect Manufacturing Corporation | Cream | Topical | 2.36 g/59.1 g | 2022 | |
Indications
| |||||
Meijer | Patch | Topical | 750 mg | 2013 | |
| |||||
Meijer | Spray | Topical | 16 g/100 g | 2021 | |
Indications
| |||||
Sklar BOV Solutions Inc | Spray | Topical | 105 mg/1 g | 2020 | |
| |||||
Meijer Distribution, Inc | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Meijer Inc | Patch | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
Meijer | Patch | Topical | 750 mg | 2013 | |
| |||||
Meijer Distribution Inc | Patch | Topical | 5 g | 2017 | |
Indications
| |||||
Meijer Distribution, Inc | Liquid | Topical | 160 mg/1 mL | 2019 | |
Indications
| |||||
Sklar BOV Solutions Inc | Spray | Topical | 160 mg/1 g | 2020 | |
| |||||
Meijer Distribution | Powder | Topical | 1 g/100 g | 2024 | |
Indications
| |||||
Meijer | Spray | Topical | 10.5 g/100 g | 2021 | |
Indications
| |||||
Meijer Distribution, Inc | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Meijer | Lozenge | Oral | 20 mg | 2024 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 5 g | 2017 | |
Indications
| |||||
Meijer | Lozenge | Oral | 2.7 mg | 2024 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 6 mg/50 mL | 2016 | |
| |||||
THE EGYPTIAN SAUDI CO FOR MEDICAL MANUFACTURING MASCOMID | Patch | Topical | 15 mg/1 g | 2018 | |
| |||||
Alexso, Inc | Cream | Topical | 40 mg/1 g | 2019 | |
Indications
| |||||
Amish Origins LLC | Cream | Topical | 8 g/100 g | 2023 | |
Indications
| |||||
Amish Origins LLC | Cream | Topical | 8 g/100 g | 2013 | |
Indications
| |||||
CHEMCO CORPORATIOM | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
FlexiGo Inc | Paste | Topical | 0.01 g/100 mL | 2025 | |
| |||||
FSA Store Inc. | Powder | Topical | 10 mg/1 g | 2023 | |
Indications
| |||||
McKesson | Lozenge | Oral | 0.7 g/1 g | 2020 | |
Indications
| |||||
McKesson | Lozenge | Oral | 0.86 g/1 g | 2020 | |
Indications
| |||||
Relief-Mart, Inc | Spray | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
SUNSET PAIN RELIEF | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
SUNSET PAIN RELIEF ROLL-ON 3OZ | Gel | Topical | 4 g/100 mL | 2019 | |
Indications
| |||||
Target Corporation | Powder | Topical | 10 mg/1 g | 2025 | |
Indications
| |||||
Topco Associates LLC | Powder | Topical | 2.8 g/283 g | 2019 | |
Indications
| |||||
Unexo Life Sciences Private Limited | Patch | Topical | 105 mg | 2022 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Powder | Topical | 2.8 g/283 g | 2019 | |
Indications
| |||||
Unexo Life Sciences, Private Limited | Patch | Topical | 440 mg | 2018 | |
Indications
| |||||
Unexo Life Sciences, Private Limited | Patch | Topical | 600 mg | 2020 | |
Indications
| |||||
Unexo Life Sciences, Private Limited | Patch | Topical | 910 mg | 2020 | |
Indications
| |||||
HEB | Lozenge | Oral | 5.4 mg | 2013 | |
Indications
| |||||
Safeway Inc. | Lozenge | Oral | 5.4 mg | 2014 | |
Indications
| |||||
The Kroger Co. | Lozenge | Oral | 5.4 mg | 2014 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 5.4 mg | 2016 | |
Indications
| |||||
American Sales | Lozenge | Oral | 5.4 mg | 2016 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 5.4 mg | 2018 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
Indications
| |||||
Boston Nutraceutical Production SL | Pastille | Oral | 5.8 mg | 2019 | |
Indications
| |||||
BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 5.4 mg | 2022 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 5.4 mg | 2013 | |
Indications
| |||||
Family Dollar | Lozenge | Oral | 5.4 mg | 2013 | |
Indications
| |||||
Meijer | Lozenge | Oral | 5.4 mg | 2017 | |
Indications
| |||||
Meijer Distribution Inc. | Lozenge | Oral | 5.4 mg | 2014 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Topco Associates | Lozenge | Oral | 5.4 mg | 2013 | |
Indications
| |||||
WHOLE FOODS MARKET, INC. | Pastille | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Winco Foods | Lozenge | Oral | 5.4 mg | 2014 | |
Indications
| |||||
Winco Foods | Lozenge | Oral | 5.4 mg | 2016 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 7.6 mg | 2025 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 7.5 mg | 2025 | |
Indications
| |||||
7-ELEVEN | Lozenge | Oral | 2.5 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Genia Care Phamaceutical S. A. | Ointment | Topical | 50 mg/1 g | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 20 mg | 2023 | |
Indications
| |||||
Dollar General Corporation | Lozenge | Oral | 20 mg | 2023 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 20 mg | 2025 | |
Indications
| |||||
R. L. ALBERT & SON, INC | Lozenge | Oral | 20 mg | 2025 | |
Indications
| |||||
Army & Air Force Exchange Service | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Patch | Topical | 0.04 g/1 g | 2024 | |
Indications
| |||||
Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2023 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2024 | |
Indications
| |||||
Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2023 | |
Indications
| |||||
Guangzhou Liuquanmiao Import & Export Trade Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2023 | |
Indications
| |||||
Guangzhou Hanhai Trading Co. , Ltd | Patch | Topical | 19 g/100 1 | 2023 | |
| |||||
Medhome Pharma Inc | Liquid, Extended Release | Topical | 0.04 g/1 mL | 2024 | |
| |||||
BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 20 mg | 2020 | |
Indications
| |||||
Cloud 9 Naturally | Lotion | Topical | 1.3 g/100 g | 2018 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 2.5 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 7.6 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Tablet, Chewable, Extended Release | Oral | 2.7 mg/2850 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Tablet, Chewable, Extended Release | Oral | 2.7 mg/2850 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg/2850 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg/2850 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Medical Group Care LLC | Lozenge | Oral | 2 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 4.8 mg | 2025 | |
Indications
| |||||
Functional Energetic, Inc. | Cream | Topical | 15 mg/1 mL | 2018 | |
Indications
| |||||
Crown Laboratories | Gel | Topical | 20 mg/1 g | 2011 | |
Indications
| |||||
Winning Solutions | Cream | Topical | 0.028 g/28 g | 2011 | |
Indications
| |||||
Winning Solutions | Cream | Topical | 0.224 g/224 g | 2011 | |
Indications
| |||||
Winning Solutions | Cream | Topical | 0.224 g/224 g | 2011 | |
Indications
| |||||
Winning Solutions | Liquid | Topical | 1.8 mL/90 mL | 2006 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Cream | Topical | 3 g/100 g | 2012 | |
Indications
| |||||
Southern Sales & Services, Inc | Gel | Topical | 2 g/100 g | 2021 | |
Indications
| |||||
Biological Health Group Corporation | Cream | Topical | 1.5 g/100 mL | 2015 | |
Indications
| |||||
Avon Products, Inc. | Spray | Topical | 5 mg/1 mL | 2012 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 4.8 mg | 2015 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 2015 | |
Indications
| |||||
Mountainside Medical Equipment, Inc. | Gel | Topical | 5 g/100 mL | 2019 | |
Indications
| |||||
Mountainside Medical Equipment, Inc. | Gel | Topical | 6 g/100 mL | 2022 | |
Indications
| |||||
Dudley Wellness Company Inc | Cream | Topical | 2.5 g/100 g | 2013 | |
Indications
| |||||
DUDLEY WELLNESS COMPANY INC | Cream | Topical | 2.5 g/100 g | 2013 | |
Indications
| |||||
YIYANGYUAN LIFE SCIENCES (HONG KONG) CO. , LIMITED | Patch | Topical | 2 g/100 g | 2026 | |
| |||||
YIYANGYUAN LIFE SCIENCES (HONG KONG) CO. , LIMITED | Patch | Topical | 2 g/100 g | 2026 | |
| |||||
YIYANGYUAN LIFE SCIENCES (HONG KONG) CO. , LIMITED | Patch | Topical | 2 g/100 g | 2026 | |
| |||||
WATER-JEL TECHNOLOGIES | Gel | Topical | 3.5 g/100 mL | 2010 | |
Indications
| |||||
Discount Drug Mart, Inc. | Gel | Topical | 2.5 g/100 g | 2015 | |
Indications
| |||||
Kareway Product, Inc. | Gel | Topical | 2.5 g/100 g | 2013 | |
Indications
| |||||
Navarro Discount Pharmacies, LLC | Gel | Topical | 2.5 g/100 g | 2012 | |
Indications
| |||||
NeoPharm Co. , Ltd. | Gel | Topical | 2.5 g/100 g | 2010 | |
Indications
| |||||
LIFElabs, a Division of Atico International USA, INC. | Gel | Topical | 25 mg/1 g | 2010 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 37 mg/1 g | 2021 | |
Indications
| |||||
Anicare Pharmaceuticals Pvt. Ltd | Gel | Topical | 0.025 g/1 g | 2015 | |
Indications
| |||||
MEDZONE PRODUCTS LLC | Cream | Topical | 35 mg/1 g | 2019 | |
| |||||
OL PHARMA TECH, LLC | Gel | Topical | 25 mg/1 g | 2021 | |
Indications
| |||||
Personal Care Products, Inc. | Cream | Topical | 1.05 g/42 g | 2013 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 0.025 g/1 g | 2015 | |
Indications
| |||||
Universal Distribution Centre LLC | Gel | Topical | 25 mg/1 g | 2021 | |
Indications
| |||||
Universal Distribution Centre LLC | Gel | Topical | 25 mg/1 g | 2021 | |
Indications
| |||||
Aidance Scientific, Inc. , DBA Aidance Skincare & Topical Solutions | Cream | Topical | 4 g/100 g | 2023 | |
Indications
| |||||
Inspec Solutions LLC | Spray | Topical | 15.75 g/100 mL | 2021 | |
Indications
| |||||
Inspec Solutions LLC. | Gel | Topical | 6 g/100 mL | 2021 | |
Indications
| |||||
Inspec Solutions | Gel | Topical | 6 g/100 g | 2024 | |
| |||||
Sunascen Therapeutics LLC | Gel | Topical | 35 mg/1 mL | 2018 | |
Indications
| |||||
Patchv3 Vitamins Ltd | Tape | Topical | 10 g/100 g | 2020 | |
Indications
| |||||
Herba Enterprise Inc | Lotion | Topical | 60 mg/1 mL | 2014 | |
Indications
| |||||
Natoral Limited | Mouthwash | Oral | 0.3 mg/1 mL | 2017 | |
Indications
| |||||
NATURAL 17 | Spray | Topical | 1.7 g/100 mL | 2023 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 4.8 mg | 2023 | |
Indications
| |||||
BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 4.8 mg | 2020 | |
Indications
| |||||
BOSTON NUTRACEUTICAL PRODUCTION, S. L | Pastille | Oral | 4.8 mg | 2021 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 4.8 mg | 2020 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 2.0 mg | 1942 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 2.0 mg | 1942 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 3.5 mg | 1942 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 3.5 mg | 1942 | |
Indications
| |||||
RENU LABORATORIES, INC. | Lotion | Topical | 2.8 g/224 g | 2024 | |
Indications
| |||||
EROS GLOBAL CORP | Oil | Topical | 8 g/100 g | 2020 | |
Indications
| |||||
Natureplex LLC | Cream | Topical | 2.5 g/100 g | 2021 | |
Indications
| |||||
Unipack, Inc. | Gel | Topical | 2 g/100 g | 2014 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Spray | Topical | 160 mg/1 g | 2024 | |
Indications
| |||||
Natures Sunshine Products, Inc. | Cream | Topical | 1.25 g/100 g | 2010 | |
| |||||
Wasatch Product Development, LLC | Cream | Topical | 1.25 g/100 g | 2010 | |
| |||||
WB VENTURES LLC | Cream | Topical | 30 mg/1 g | 2021 | |
Indications
| |||||
WB Ventures LLC | Cream | Topical | 10 mg/1 g | 2023 | |
Indications
| |||||
WB Ventures LLC | Liquid | Topical | 30 mg/1 mL | 2025 | |
Indications
| |||||
WB Ventures LLC | Cream | Topical | 10 mg/1 g | 2021 | |
Indications
| |||||
NeilMed Pharmaceuticals Inc. | Spray | Topical | 0.16 g/1 g | 2020 | |
Indications
| |||||
Guoyu Trading Co. , Ltd. | Patch | Topical | 0.5 g/100 1 | 2024 | |
| |||||
Guoyu Trading Co. , Ltd. | Patch | Topical | 1 g/100 1 | 2024 | |
Indications
| |||||
TOP DOG DIRECT, LLC | Cream | Topical | 30 mg/1 mL | 2023 | |
Indications
| |||||
Pogue Medical Services | Cream | Topical | 40 mg/1 mL | 2019 | |
Indications
| |||||
Owell Naturals Brand, LLC | Cream | Topical | 4 g/100 g | 2026 | |
Indications
| |||||
Owell Naturals Brand, LLC | Cream | Topical | 8 g/100 g | 2026 | |
Indications
| |||||
ANC Amazon Natural Corp. | Spray | Topical | 5 g/100 mL | 2016 | |
Indications
| |||||
Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
Indications
| |||||
Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
Indications
| |||||
Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
Indications
| |||||
Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
Indications
| |||||
Leosons Overseas Corp | Lozenge | Oral | 5 mg | 2019 | |
Indications
| |||||
PLUM VALLEYPHARMA LLC | Cream | Topical | 3.7 g/100 g | 2022 | |
Indications
| |||||
Compes Cosmetic | Cream | Topical | 10 mg/100 mg | 2017 | |
Indications
| |||||
Lugus Group LLC | Cream | Topical | 10 mg/100 mg | 2014 | |
Indications
| |||||
LUGUS GROUP LLC | Spray | Topical | 0.1 mg/100 mg | 2016 | |
Indications
| |||||
Lugus Group LLC | Aerosol, Spray | Topical | 5 mg/100 mg | 2017 | |
Indications
| |||||
Lugus Group LLC | Liquid | Topical | 10 mg/100 mg | 2017 | |
Indications
| |||||
Lugus Group LLC | Aerosol, Spray | Topical | 5 mg/100 mg | 2018 | |
Indications
| |||||
Lugus Group LLC | Aerosol, Foam | Topical | 5 mg/100 mg | 2014 | |
Indications
| |||||
Vema Industrie-Verpackung | Aerosol, Foam | Topical | 5 mg/100 mg | 2017 | |
Indications
| |||||
Vema Industrie-Verpackung | Cream | Topical | 10 mg/100 mg | 2017 | |
Indications
| |||||
Vema Industrie-verpackung Gmbh & Co. Kg. Kontrakt - Abfullung Und -verpackung | Aerosol, Spray | Topical | 5 mg/100 mg | 2017 | |
Indications
| |||||
Vema Industrie-verpackung Gmbh & Co. Kg. Kontrakt - Abfullung Und -verpackung | Spray | Topical | 0.1 mg/100 mg | 2016 | |
Indications
| |||||
DreamAir Co. , | Liquid | Topical | 0.2 g/10 mL | 2016 | |
Indications
| |||||
Xcentrik Inc. | Cream | Topical | 3 g/100 g | 2019 | |
Indications
| |||||
NOVUM SOLUTIONS INC | Spray | Topical | 0.5 g/100 mL | 2015 | |
Indications
| |||||
FlexiGo Inc | Cream | Topical | 1 g/100 mL | 2025 | |
| |||||
FlexiGo Inc | Cream | Topical | 1 g/100 g | 2025 | |
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
Hobart Laboratories, Inc. | Ointment | Topical | 1.25 g/100 g | 2011 | |
Indications
| |||||
Nuturna International LLC | Cream | Topical | 3.7 g/100 g | 2020 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
Phytopia Co. , Ltd. | Oil | Transdermal | 100 mg/50 mL | 2016 | |
Indications
| |||||
NATURAL ESSENTIALS, INC. | Gel | Topical | 100 mg/1 g | 2024 | |
Indications
| |||||
Jakemans (Confectioners) Limited | Lozenge | Oral | 10 mg | 2010 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| |||||
WORLD WIDE MEDICAL SERVICES, INC. | Gel | Topical | 3.9 g/100 mL | 2015 | |
Indications
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
Indications
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 4.2 g/84 g | 2021 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
Indications
| |||||
Renu Laboratories, Inc. | Cream | Topical | 5.6 g/112 g | 2021 | |
Indications
| |||||
Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 10 mg | 2010 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 5.5 mg | 2022 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 5.5 mg | 2022 | |
Indications
| |||||
Valda USA Labeler | Lozenge | Oral | 3.6 mg | 2024 | |
Indications
| |||||
LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 g | 2025 | |
Indications
| |||||
LiquidCapsule Manufacturing LLC | Gel | Topical | 3.5 g/100 mL | 2025 | |
Indications
| |||||
Sarati International, Inc. | Cream | Topical | 1.3 g/100 g | 2016 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 7 mg/50 mL | 2016 | |
| |||||
Walgreen Co. | Gel | Topical | 36 mg/1 mL | 2023 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.04 g/1 g | 2025 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2022 | |
Indications
| |||||
OWELL NATURALS BRAND, LLC | Ointment | Topical | 76.6 mg/1 mL | 2024 | |
Indications
| |||||
Owell Naturals Brand LLC | Cream | Topical | 8 g/100 mL | 2024 | |
Indications
| |||||
Back to Earth Inc. | Cream | Topical | 9.6 mg/1 mL | 2023 | |
Indications
| |||||
Genexa Inc. | Gel | Topical | 7 g/100 mL | 2018 | |
Indications
| |||||
Austin Biotechnology Inc | Cream | Topical | 14 g/280 g | 2011 | |
Indications
| |||||
Natures Formulae Health Products Ltd. | Granule | Topical | 1.6 mg/1 g | 2016 | |
| |||||
Natures Formulae Health Products Ltd. | Oil | Topical | 17.62 mg/1 mL | 2016 | |
Indications
| |||||
Natures Formulae Health Products Ltd. | Oil | Topical | 12.18 mg/1 mL | 2016 | |
Indications
| |||||
Saje Natural Business Inc. | Granule | Topical | 1.6 mg/1 g | 2016 | |
| |||||
Saje Natural Business Inc. | Oil | Topical | 17.62 mg/1 mL | 2016 | |
Indications
| |||||
Saje Natural Business Inc. | Oil | Topical | 12.18 mg/1 mL | 2016 | |
Indications
| |||||
Saje Natural Business Inc. | Liquid | Topical | 2.23 mg/1 mL | 2016 | |
Indications
| |||||
Saje Natural Business Inc. | Cream | Topical | 2.667 g/100 g | 2024 | |
Indications
| |||||
Better Living Brands | Spray | Topical | 10.5 g/100 g | 2018 | |
Indications
| |||||
J. R. Watkins, LLC. | Aerosol, Spray | Topical | 6 g/100 mL | 2020 | |
Indications
| |||||
J. R. Watkins, LLC. | Gel | Topical | 6 g/100 g | 2020 | |
Indications
| |||||
J. R. Watkins, LLC. | Patch | Topical | 105 mg | 2022 | |
Indications
| |||||
Pain Relieving Spray Inc. | Aerosol, Spray | Topical | 70 mg/1 L | 2025 | |
Indications
| |||||
Sagely Enterprises Inc. | Spray | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Patch | Topical | 0.05 g/1 g | 2025 | |
Indications
| |||||
Trifecta Pharmaceuticals USA, LLC. | Spray | Topical | 10.5 g/100 mL | 2026 | |
Indications
| |||||
Unifirst First Aid Corporation | Spray | Topical | 70 mg/1 L | 2019 | |
Indications
| |||||
HEMPFUSION, INC. | Cream | Topical | 40 mg/1 g | 2020 | |
Indications
| |||||
SOTAC PHARMACEUTICAL PRIVATE LIMITED | Gel | Topical | 40 mg/1 mL | 2021 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Cream | Topical | 6 g/100 mL | 2018 | |
Indications
| |||||
HEMPFUSION, INC. | Cream | Topical | 17.5 mg/1 mL | 2020 | |
Indications
| |||||
Sagely Enterprises Inc. | Cream | Topical | 5 g/100 g | 2021 | |
Indications
| |||||
SanaMax Plus LLC | Cream | Topical | 1.25 g/100 g | 2019 | |
Indications
| |||||
HEMPFUSION, INC. | Gel | Topical | 15 mg/1 mL | 2020 | |
Indications
| |||||
R & Y Group, LLC | Gel | Topical | 0.04 g/1 mL | 2023 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2022 | |
Indications
| |||||
Bullet point LLC | Gel | Topical | 0.04 g/1 mL | 2025 | |
Indications
| |||||
Shanghai Chuangshi Medical Technology (Group) Co. , Ltd. | Gel | Topical | 0.04 g/1 mL | 2022 | |
Indications
| |||||
Great Lakes Wholesale, Marking, and Sales, Inc. | Liquid | Topical | 0.16 g/1 mL | 2016 | |
Indications
| |||||
J. R. Watkins, LLC. | Gel | Topical | 6 g/100 g | 2020 | |
Indications
| |||||
Sagely Enterprises Inc. | Liquid | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
Better Living | Gel | Topical | 4 g/100 mL | 2018 | |
Indications
| |||||
Great Lakes Wholesale, Marketing, and Sales, Inc | Patch | Topical | 160 mg/1 mL | 2016 | |
Indications
| |||||
Sagely Enterprises Inc. | Stick | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
UNITED EXCHANGE CORP | Patch | Topical | 750 mg | 2013 | |
| |||||
CA-BOTANA INTERNATIONAL | Gel | Topical | 2.4 g/120 g | 2011 | |
| |||||
Safetec of America, Inc. | Gel | Topical | 4 g/100 g | 2019 | |
Indications
| |||||
Safetec of America, Inc. | Spray | Topical | 7 g/100 mL | 2019 | |
Indications
| |||||
AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 L | 2016 | |
Indications
| |||||
AHC VENTURES CORP DBA CRYODERM | Gel | Topical | 10 g/100 L | 2016 | |
Indications
| |||||
J. R. Watkins, LLC. | Gel | Topical | 3 g/100 g | 2019 | |
Indications
| |||||
Rite Aid Corporation | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Heilongjiang Huashen Science & Technology Development Co Ltd | Patch | Topical | 0.2 | 2010 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | .05 mg/1 g | 2013 | |
Indications
| |||||
CVS PHARMACY, INC. | Patch | Topical | 50 mg/1 g | 2013 | |
Indications
| |||||
Safetec of America, Inc. | Gel | Topical | 7 g/100 mL | 2019 | |
Indications
| |||||
Koi CBD LLC | Gel | Topical | 100 mg/1 mL | 2020 | |
Indications
| |||||
OL PHARMA TECH, LLC | Gel | Topical | 25 mg/1 g | 2021 | |
Indications
| |||||
VIZURI HEALTH SCIENCES LLC | Patch | Topical | 6 g | 2021 | |
Indications
| |||||
VIZURI HEALTH SCIENCES LLC | Patch | Topical | 6 g | 2022 | |
Indications
| |||||
PainFix LLC | Gel | Topical | 50 mg/1 g | 2019 | |
Indications
| |||||
PainFix LLC | Patch | Topical | 70 mg/1 g | 2022 | |
Indications
| |||||
PainFix LLC | Patch | Topical | 30 mg/1 mL | 2019 | |
Indications
| |||||
NACOR BUSINESS GROUP LLC | Gel | Topical | 3 g/100 g | 2025 | |
Indications
| |||||
SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2019 | |
Indications
| |||||
SmartScience Laboratories, Inc. | Gel | Topical | 85 mg/1 mL | 2019 | |
Indications
| |||||
MEDZONE PRODUCTS LLC | Cream | Topical | 35 mg/1 g | 2019 | |
| |||||
Enzyme Labs | Cream | Topical | 4.25 g/85 g | 2010 | |
Indications
| |||||
NHR SCIENCE CORP | Cream | Topical | 15 mg/1 mL | 2022 | |
Indications
| |||||
Meds Direct Rx of NY LLC | Patch | Topical | 5 g/100 g | 2014 | |
| |||||
RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2015 | |
Indications
| |||||
RB Health (US) LLC | Gel | Topical | 35 mg/1 mL | 2015 | |
Indications
| |||||
Delta Brands & Products LLC | Gel | Topical | 1.25 g/100 g | 2018 | |
Indications
| |||||
Personal Care Products, Inc. | Powder | Topical | 20 mg/2 g | 2009 | |
Indications
| |||||
PERSONAL CARE PRODUCTS, LLC | Patch | Topical | 50 mg | 2011 | |
| |||||
NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO. , LTD. | Gel | Topical | 1.25 g/100 g | 2017 | |
Indications
| |||||
Personal Care Products, Inc. | Gel | Topical | 1 g/100 g | 2010 | |
Indications
| |||||
American Consumer Products Corp | Gel | Topical | 1 g/100 g | 2018 | |
Indications
| |||||
ER3 BRANDS INC. | Cream | Topical | 10 mg/1 mL | 2025 | |
Indications
| |||||
Pure Source, LLC | Cream | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
Acme United Corporation | Lozenge | Oral | 7.6 mg | 2015 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
PlayMakar Inc. | Gel | Topical | 60 mg/1 mL | 2019 | |
Indications
| |||||
PO SUM ON MEDICINE FACTORY LIMITED | Ointment | Topical | 13 g/100 g | 2017 | |
Indications
| |||||
PO SUM ON MEDICINE FACTORY LIMITED | Oil | Topical | 15 g/100 mL | 2004 | |
Indications
| |||||
Fabrication Enterprises | Gel | Topical | 120 mg/1 g | 2019 | |
Indications
| |||||
FABRICATION ENTERPRISES | Gel | Topical | 120 mg/1 mL | 2024 | |
Indications
| |||||
Fabrication Enterprises | Gel | Topical | 120 mg/1 mL | 2019 | |
Indications
| |||||
Fabrication Enterprises | Liquid | Topical | 140 mg/1 mL | 2019 | |
Indications
| |||||
Mettler Electronics Corp. | Gel | Topical | 40 mg/1 mL | 2002 | |
Indications
| |||||
Clientele, Inc. | Gel | Topical | 2 mL/100 mL | 2004 | |
Indications
| |||||
Amphp, Inc | Lotion | Topical | 0.5 g/100 g | 2018 | |
Indications
| |||||
Pharmacy Value Alliance LLC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Pharmacy Value Alliance LLC | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Pharmacy Value Alliance LLC | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Pharmacy Value Alliance LLC | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Premiere Enterprises | Spray | Topical | 0.07 g/1 mL | 2010 | |
Indications
| |||||
Premiere Enterprises | Spray | Topical | 7 g/100 mL | 2011 | |
Indications
| |||||
Premiere Enterprises | Spray | Topical | 7 g/100 mL | 2011 | |
Indications
| |||||
DOBEST INC | Cream | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
Guangzhou Zhupuyou E-commerce Co. , Ltd | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
TWIN MED, LLC | Gel | Topical | 5 g/100 g | 2016 | |
Indications
| |||||
New Leaf Pharmaceutical, LLC | Spray | Topical | 10.5 g/10.5 mL | 2019 | |
| |||||
NATURE'S FUSIONS, LLC | Cream | Topical | 4 g/60 mL | 2022 | |
| |||||
Guangzhou Haishi Biological Technology Co. , Ltd. | Cream | Topical | 10 g/100 g | 2025 | |
| |||||
Guangzhou Haishi Biological Technology Co. , Ltd. | Cream | Topical | 10 g/100 g | 2025 | |
| |||||
AHC VENTURES | Spray | Topical | 8 g/100 mL | 2016 | |
Indications
| |||||
ACH VENTURES CORP | Gel | Topical | 8 g/100 mL | 2016 | |
Indications
| |||||
New Leaf Pharmaceutical, LLC | Gel | Topical | 10.5 g/10.5 mL | 2020 | |
| |||||
New Leaf Pharmaceutical, LLC | Ointment | Topical | 16 g/16 mg | 2020 | |
| |||||
PURE PERSONAL CARE, LLC | Cream | Topical | 75 mg/1 mL | 2022 | |
Indications
| |||||
CHAIN DRUG MARKETING ASSOCIATION INC | Patch | Topical | 400 mg | 2011 | |
Indications
| |||||
Quality Home Products | Patch | Topical | 400 mg | 2011 | |
Indications
| |||||
Chain Drug Marketing Association Inc | Liquid | Topical | 16 g/100 g | 2021 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.4 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.5 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 7.6 mg | 2023 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.7 mg | 2023 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 5.8 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 2.5 mg | 2024 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Lozenge | Oral | 2.5 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 7.5 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 7.6 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association, Inc. | Lozenge | Oral | 5.4 mg | 2024 | |
Indications
| |||||
Chain Drug Marketing Association | Gel | Topical | 2.5 g/100 g | 2011 | |
Indications
| |||||
Quality Home Products | Gel | Topical | 2.5 g/100 g | 2011 | |
Indications
| |||||
Quantum, Inc. | Lozenge | Oral | 5 mg | 2017 | |
Indications
| |||||
Quantum, Inc. | Lozenge | Oral | 5 mg | 2017 | |
Indications
| |||||
Access Business Group International LLC | Cream | Topical | 1.25 g/100 g | 2010 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.75 g/100 mL | 2022 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2024 | |
Indications
| |||||
Troy Manufacturing, Inc. | Liquid | Topical | 100 mg/1 mL | 2024 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2024 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2024 | |
Indications
| |||||
RAPID AID VIET NAM COMPANY LIMITED | Patch | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
RAPID AID VIET NAM COMPANY LIMITED | Patch | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
RAPID AID VIET NAM COMPANY LIMITED | Patch | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
RAPID AID VIET NAM COMPANY LIMITED | Patch | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
RAPID AID VIET NAM CO. , LTD | Patch | Topical | 4.26 g/100 g | 2024 | |
Indications
| |||||
RAPID AID VIET NAM CO. , LTD | Patch | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
Rapid-Ease | Cream | Topical | 12.5 mg/1 g | 2019 | |
Indications
| |||||
Raw Health International, LLC | Liquid | Topical | 34.86 g/1 L | 2013 | |
Indications
| |||||
Rescue Dog Health | Gel | Topical | 3.5 mg/1 L | 2014 | |
Indications
| |||||
Raw Health International, LLC | Liquid | Topical | 34.79 g/1 L | 2013 | |
Indications
| |||||
Rescue Dog Health | Gel | Topical | 3.5 mg/1 L | 2014 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2016 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.03 g/1 g | 2022 | |
Indications
| |||||
Rejuventus, Inc. | Cream | Topical | 118.29 mL/100 mL | 2011 | |
| |||||
Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.25 g/100 mL | 2013 | |
Indications
| |||||
Real Time Products Inc. | Cream | Topical | 15 mg/1 g | 2024 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Cream | Topical | 1.5 g/100 g | 2013 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.5 g/100 mL | 2014 | |
Indications
| |||||
Real Time Products Inc. | Lotion | Topical | 19 mg/1 mL | 2024 | |
Indications
| |||||
REAL TIME PRODUCTS, INC | Lotion | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Lotion | Topical | 0.5 g/100 mL | 2013 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Lotion | Topical | 1.25 g/100 mL | 2013 | |
Indications
| |||||
VRB Labs, LLC | Gel | Topical | 85 mg/1 mL | 2020 | |
Indications
| |||||
Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Cream | Topical | 3 g/100 g | 2012 | |
Indications
| |||||
Redicare LLC | Lozenge | Oral | 7.6 mg/100 mg | 2025 | |
Indications
| |||||
Inspec Solutions LLC. | Spray | Topical | 10.5 g/100 g | 2024 | |
Indications
| |||||
La Mend, Inc. | Patch | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
Beone Co. , Ltd. | Patch | Topical | 4 g/100 g | 2026 | |
Indications
| |||||
Corganics, LP | Cream | Topical | 2.5 g/100 g | 2004 | |
Indications
| |||||
Corganics, LP | Cream | Topical | 3.0 g/100 g | 2004 | |
Indications
| |||||
Proximity Capital Partners LLC dba Asutra | Cream | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
SOLITEINT Kozmetikum gyarto es forgalmazo, termelo es kereskedelmi Korlatolt Felelossegu Tarsasag | Cream | Topical | 10 g/100 g | 2021 | |
Indications
| |||||
Cosmetic Specialty labs, Inc. | Liquid | Topical | 1.2 mg/15 mL | 2020 | |
Indications
| |||||
Midas-Care Pharmaceuticals, Pvt. Ltd | Aerosol, Spray | Topical | 4 g/100 g | 2025 | |
Indications
| |||||
Saje Natural Business Inc. | Ointment | Topical | 0.2 g/100 g | 2018 | |
Indications
| |||||
International Nutraceutical Company of America (INCA) , LLC | Ointment | Topical | 937.5 mg/1 g | 2012 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.5 g/100 mL | 2021 | |
Indications
| |||||
EEZAWAY RELIEF INC | Liquid | Topical | 2.75 g/100 mL | 2022 | |
Indications
| |||||
Dolgencorp, LLC | Gel | Topical | 2 g/100 g | 2018 | |
Indications
| |||||
DOLGENCORP, LLC | Gel | Topical | 27.5 mg/1 g | 2011 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 7 mg/50 mL | 2016 | |
| |||||
Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
RICHTOFIT LIMITED LIABILITY COMPANY | Cream | Topical | 1.5 g/100 g | 2026 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 8.3 mg | 2022 | |
Indications
| |||||
Rite Aid | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
Rite Aid | Spray | Topical | 10.5 g/100 g | 2021 | |
Indications
| |||||
Rite Aid | Patch | Topical | 750 mg | 2013 | |
| |||||
Rite Aid | Patch | Topical | 750 mg | 2013 | |
| |||||
Rite Aid Corporation | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
Rite Aid | Liquid | Topical | 16 g/100 g | 2023 | |
Indications
| |||||
SOTAC PHARMACEUTICALS PRIVATE LIMITED | Gel | Topical | 40 mg | 2018 | |
Indications
| |||||
Velocity Pharma LLC | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Ningbo Pulisi Daily Chemical Products Co. , Ltd. | Cream | Topical | 6 mg/100 mL | 2017 | |
Indications
| |||||
Ningbo Pulisi Daily Chemical Products Co. , Ltd. | Cream | Topical | 0.006 g/0.1 g | 2017 | |
Indications
| |||||
NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Cream | Topical | 6 mg/100 mL | 2019 | |
Indications
| |||||
NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Gel | Topical | 6.0 g/100 g | 2019 | |
Indications
| |||||
NINGBO SANTE YING MEDICALAND HEALTHDEVELOPMENT CO. , LTD | Gel | Topical | 6.0 g/100 g | 2019 | |
Indications
| |||||
Implus Footcare, LLC | Gel | Topical | 8.3 g/88.5 mL | 2021 | |
Indications
| |||||
Implus Footcare, LLC | Gel | Topical | 33.2 g/355 mL | 2021 | |
Indications
| |||||
New Leaf Pharmaceutical, LLC | Spray | Topical | 4 g/4 mL | 2019 | |
| |||||
Awesome Trading, LLC | Cream | Topical | 50 mg/1 mL | 2020 | |
Indications
| |||||
Rugby Laboratories | Gel | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
RUGBY LABORATORIES | Patch | Topical | 5 g/100 g | 2021 | |
Indications
| |||||
Saint Medicine, Inc. | Liquid | Respiratory (inhalation) | 3.2 g/100 mL | 2023 | |
Indications
| |||||
Alquimia Najulam S de RL de CV | Gel | Topical | 150 mg/1 g | 2018 | |
Indications
| |||||
SanaMax Plus LLC | Cream | Topical | 4.0 g/100 mL | 2022 | |
Indications
| |||||
Miracle Balance, LLC | Cream | Topical | 50 mg/1 mL | 2020 | |
Indications
| |||||
Q. A. Laboratories | Cream | Topical | 4 g/100 g | 2012 | |
Indications
| |||||
Sella Natural Cosmetics Co. , Ltd. | Paste, Dentifrice | Topical | 0.2 g/100 g | 2014 | |
| |||||
Target Corporation Inc. | Pastille | Oral | 20 mg | 2024 | |
Indications
| |||||
Target Corporation Inc. | Pastille | Oral | 0.69 mg | 2019 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 7.6 mg | 2016 | |
Indications
| |||||
Meijer Distribution | Lozenge | Oral | 7.6 mg | 2018 | |
Indications
| |||||
The Kroger Co. | Lozenge | Oral | 7.6 mg | 2014 | |
Indications
| |||||
HEB | Lozenge | Oral | 5.8 mg | 2012 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
Corporativo Serysi S de R L de C V | Gel | Topical | 12.5 mg/1 g | 2017 | |
| |||||
Corporativo Serysi S de R L de C V | Gel | Topical | 12.6 mg/1 g | 2017 | |
| |||||
Corporativo Serysi S de R L de C V | Gel | Topical | 2.6 mg/100 g | 2017 | |
| |||||
Shield and Heal Inc. | Stick | Topical | 10 mg/1 g | 2021 | |
Indications
| |||||
Safeway | Lozenge | Oral | 5.8 mg | 2020 | |
Indications
| |||||
Safeway | Patch | Topical | 50 mg | 2015 | |
Indications
| |||||
Safeway | Lozenge | Oral | 7.5 mg | 2020 | |
Indications
| |||||
Safeway | Patch | Topical | 5 g/100 g | 2023 | |
Indications
| |||||
Safeway | Gel | Topical | 4 g/1 mL | 2024 | |
Indications
| |||||
ALPHA PLANTS INC | Cream | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
Sinsin Pharmaceutical Co. , Ltd. | Patch | Topical | 0.85 g/17 g | 2018 | |
Indications
| |||||
Avon Products, Inc. | Spray | Topical | 5 mg/1 mL | 2012 | |
Indications
| |||||
Kmart Corporation | Patch | Topical | 750 mg | 2013 | |
| |||||
Smooth Gator LLC | Cream | Topical | 30 mg/1 mL | 2024 | |
Indications
| |||||
Natumin Pharma AB | Gel | Topical | 2.25 g/100 g | 2015 | |
| |||||
RENU LABORATORIES, INC. | Liquid | Topical | 0.84 g/28 g | 2022 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Cream | Topical | 0.06 g/1 g | 2016 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
Sombra Cosmetics Inc. | Gel | Topical | 0.06 g/1 g | 2022 | |
Indications
| |||||
Sombra Cosmetics Inc. | Gel | Topical | 0.06 g/1 g | 2022 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2020 | |
Indications
| |||||
Clay Therapy | Cream | Topical | 25 mg/1 mL | 2021 | |
Indications
| |||||
Wise Consumer Products | Oil | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Wise Consumer Products | Lotion | Topical | 1.3 g/100 g | 2025 | |
Indications
| |||||
Clientele, Inc. | Gel | Topical | 2 mg/100 mL | 2014 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2023 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2016 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2022 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | 0.06 g/1 g | 2022 | |
Indications
| |||||
United Exchange Corp. | Patch | Topical | 50 mg/1 g | 2015 | |
| |||||
Kareway Product, Inc. | Patch | Topical | 400 mg | 2018 | |
Indications
| |||||
HEMPFUSION, INC. | Cream | Topical | 40 mg/1 g | 2020 | |
Indications
| |||||
HEMPFUSION, INC. | Cream | Topical | 17.5 mg/1 mL | 2020 | |
Indications
| |||||
MIKYEONG KOREA CO. , LTD | Liquid | Topical | 4 g/100 mL | 2021 | |
| |||||
Natural Essentials Inc. | Liquid | Topical | 100 mg/1 mL | 2023 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2023 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2022 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2017 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 g | 2017 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2021 | |
Indications
| |||||
Troy Manufacturing, Inc. | Liquid | Topical | 100 mg/1 mL | 2020 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 100 mg/1 mL | 2017 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 g | 2023 | |
Indications
| |||||
Troy Manufacturing, Inc. | Spray | Topical | 80 mg/1 mL | 2018 | |
Indications
| |||||
Troy Manufacturing, Inc. | Spray | Topical | 80 mg/1 mL | 2025 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 g | 2025 | |
Indications
| |||||
Troy Manufacturing, Inc. | Gel | Topical | 80 mg/1 mL | 2022 | |
Indications
| |||||
Walgreen Co. | Lozenge | Oral | 2.7 mg | 2016 | |
Indications
| |||||
BestCo Inc. | Lozenge | Oral | 2.7 mg | 2011 | |
Indications
| |||||
HEB | Lozenge | Oral | 2.7 mg | 2018 | |
Indications
| |||||
Stressa Incorporated | Oil | Topical | 1 g/93 mL | 2014 | |
Indications
| |||||
Stressa Incorporated | Cream | Topical | 1.25 g/100 g | 2012 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 5.8 mg | 2018 | |
Indications
| |||||
Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 6.9 mg | 2010 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 5.8 mg | 2025 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 7.6 mg | 2023 | |
Indications
| |||||
CVS Pharmacy | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 7.6 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Topco Associates LLC | Pastille | Oral | 5.8 mg | 2022 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 5.8 mg | 2023 | |
Indications
| |||||
Cardinal Health 110, Inc. | Pastille | Oral | 7.6 mg | 2023 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 4.1 mg | 1942 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 4.1 mg | 1942 | |
Indications
| |||||
American Sales | Lozenge | Oral | 7.6 mg | 2016 | |
Indications
| |||||
Bestco Inc. | Lozenge | Oral | 7.6 mg | 2018 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 7.6 mg | 2015 | |
Indications
| |||||
Meijer | Lozenge | Oral | 7.6 mg | 2017 | |
Indications
| |||||
Topco Associates | Lozenge | Oral | 7.6 mg | 2013 | |
Indications
| |||||
Walgreen | Lozenge | Oral | 7.6 mg | 2019 | |
Indications
| |||||
Walmart | Lozenge | Oral | 7.6 mg | 2018 | |
Indications
| |||||
Lofthouse of Fleetwood, Ltd. | Lozenge | Oral | 5.52 mg | 2019 | |
| |||||
American Sales | Lozenge | Oral | 5.8 mg | 2016 | |
Indications
| |||||
CVS Pharmacy | Lozenge | Oral | 5.8 mg | 2015 | |
Indications
| |||||
Meijer | Lozenge | Oral | 5.8 mg | 2017 | |
Indications
| |||||
Topco Associates | Lozenge | Oral | 5.8 mg | 2013 | |
Indications
| |||||
Winco Foods | Lozenge | Oral | 5.8 mg | 2014 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 1942 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 4.8 mg | 1942 | |
Indications
| |||||
RENU LABORATORIES, LLC | Cream | Topical | 5.9 g/118 mL | 2023 | |
Indications
| |||||
Sunflora Inc. | Spray | Topical | 6 g/100 mL | 2025 | |
Indications
| |||||
SUNSET NOVELTIES, INC | Gel | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
Indications
| |||||
BLUE SPRING WELLNESS | Cream | Topical | 14 mg/1 mL | 2024 | |
Indications
| |||||
BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
Indications
| |||||
BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
Indications
| |||||
BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2020 | |
Indications
| |||||
BLUE SPRING WELLNESS, L. L. C. | Cream | Topical | 14 mg/1 mL | 2021 | |
Indications
| |||||
Superior Trading Company | Liniment | Transdermal | 3.5 mg/100 mL | 2009 | |
Indications
| |||||
Saje Natural Business Inc. | Oil | Topical | 24.56 mg/1 mL | 2016 | |
| |||||
GENUINE INNOVATION LTD | Cream | Topical | 1 mg/1 g | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 5 g/100 g | 2026 | |
Indications
| |||||
iON Pharma, LLC | Gel | Topical | 4 g | 2025 | |
Indications
| |||||
Davion, Inc | Powder | Topical | 0.15 g/100 g | 2018 | |
Indications
| |||||
TARGET CORPORATION | Gel | Topical | 40 mg/1 mL | 2023 | |
Indications
| |||||
Sod-e Biotech Ltd | Cream | Topical | 12.5 mg/1 g | 2024 | |
Indications
| |||||
PHYTOPIA CO. , LTD. | Oil | Topical | 1.3 mg/50 mg | 2016 | |
| |||||
Carbon Innovation, Inc. | Patch | Topical | 4 g/100 g | 2017 | |
Indications
| |||||
Smart Cookie Solutions | Cream | Topical | 100 mg/1 mL | 2025 | |
Indications
| |||||
Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Beijing Taiji Jin Kang Medical Technology Co. , Ltd. | Cream | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 5.3 mg | 1942 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 4.8 mg | 1942 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 4.8 mg | 1942 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 5.3 mg | 1942 | |
Indications
| |||||
Symedic LLC | Gel | Topical | 4 g/100 mL | 2019 | |
Indications
| |||||
The Cream Skateboarding Liniment Pty Ltd | Cream | Topical | 130 mg/1 g | 2018 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g/100 g | 2020 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g/100 g | 2018 | |
Indications
| |||||
Fourstar Group USA, Inc. | Gel | Topical | 40 mg/1 mL | 2024 | |
Indications
| |||||
Fourstar Group USA, Inc. | Liquid | Topical | 160 mg/1 mL | 2024 | |
Indications
| |||||
FOURSTAR GROUP USA, INC. | Gel | Topical | 25 mg/1 g | 2025 | |
Indications
| |||||
Veridian Healthcare | Patch | Topical | 5 g | 2024 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 20 mg/1 g | 2022 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 2.5 g/100 g | 2026 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 16 g/100 mL | 2026 | |
Indications
| |||||
Veridian Healthcare | Spray | Topical | 10.5 mg/1 mL | 2026 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 2 g/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 25 mg/1 g | 2021 | |
Indications
| |||||
Veridian Healthcare | Liquid | Topical | 0.16 g/1 mL | 2025 | |
Indications
| |||||
Veridian Healthcare | Gel | Topical | 4 g/1 mL | 2025 | |
Indications
| |||||
SOMBRA COSMETICS INC. | Gel | Topical | .04 g/1 g | 2013 | |
Indications
| |||||
SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
Indications
| |||||
SKIN SHERPA NORTH AMERICA LLC | Gel | Topical | 40 mg/1 mL | 2022 | |
Indications
| |||||
Epic Laboratories, LLC | Liquid | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
TopCare | Gel | Topical | 2 g/100 g | 2012 | |
Indications
| |||||
APEX-CAREX HEATHCARE PRODUCTS | Gel | Topical | 3.9 g/100 mL | 2015 | |
Indications
| |||||
APEX-CAREX HEATHCARE PRODUCTS | Gel | Topical | 3.9 g/100 mL | 2015 | |
Indications
| |||||
APEX-CAREX HEATHCARE PRODUCTS | Spray | Topical | 6 g/100 mL | 2015 | |
Indications
| |||||
Product Quest Mfg | Gel | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Thompson Safety LLC | Lozenge | Oral | 7.6 mg | 2021 | |
Indications
| |||||
Binger Consulting Corporation | Patch | Topical | 5 g/100 g | 2015 | |
Indications
| |||||
Phytoneering Extract Solutions GmbH | Pastille | Oral | 2.5 mg | 2005 | |
Indications
| |||||
Traditional Medicinals, Inc. | Lozenge | Oral | 5 mg/4.2 g | 2020 | |
Indications
| |||||
Traditional Medicinals, Inc. | Lozenge | Oral | 6 mg/4.2 g | 2020 | |
Indications
| |||||
Traditional Medicinals, Inc. | Lozenge | Oral | 6 mg/4.2 g | 2020 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 3.4 mg | 2026 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 3.4 mg | 2026 | |
Indications
| |||||
Ricola Ag | Lozenge | Oral | 3.6 mg | 2026 | |
Indications
| |||||
Ricola USA Inc. | Lozenge | Oral | 3.6 mg | 2026 | |
Indications
| |||||
Shenzhen Sam Technology Co. , Ltd. | Cream | Topical | 5 g/0.1 L | 2025 | |
Indications
| |||||
The Anthos Group, Inc | Liquid | Topical | 10.5 g/100 mL | 2023 | |
Indications
| |||||
Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Sam Technology Co. , Ltd. | Spray | Topical | 10.5 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Sam Technology Co. , Ltd. | Cream | Topical | 4 g/100 mL | 2025 | |
Indications
| |||||
ANTHOS GROUP, INC, THE | Cream | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
ANTHOS GROUP, INC, THE | Spray | Topical | 10.5 g/100 mL | 2020 | |
Indications
| |||||
Guangzhou Hanhai Trading Co. , Ltd | Patch | Topical | 19 g/100 1 | 2023 | |
Indications
| |||||
LAB-O Corp | Ointment | Topical | 24 mg/1 g | 2020 | |
Indications
| |||||
IDEAZ, LLC | Cream | Topical | 4 g/100 g | 2025 | |
Indications
| |||||
Tommie Copper, Inc. | Spray | Topical | 16 g/100 g | 2020 | |
Indications
| |||||
Topco Associates LLC | Patch | Topical | 50 mg | 2019 | |
| |||||
Topco Associates LLC | Liquid | Topical | 160 mg/1 mL | 2020 | |
Indications
| |||||
Topco Associates LLC | Gel | Topical | 40 mg/1 mL | 2020 | |
Indications
| |||||
Dermaline USA Corp | Gel | Topical | 1 g/100 g | 2021 | |
Indications
| |||||
Youngevity International Inc. | Cream | Topical | 1.4 g/100 g | 2020 | |
Indications
| |||||
AmperSand Biopharma | Lotion | Topical | 0.5 g/100 g | 2017 | |
| |||||
Yantai Aien Biotechnology Co. , Ltd. | Gel | Topical | 0.1 g/100 g | 2026 | |
| |||||
Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 150 mg | 2020 | |
Indications
| |||||
Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 300 mg | 2020 | |
Indications
| |||||
Icure Pharmaceutical Inc, Wanju Factory | Patch | Topical | 375 mg | 2020 | |
Indications
| |||||
Electrostim Medical Services Inc. d/b/a EMSI | Gel | Topical | 5.0 g/100 mL | 2019 | |
Indications
| |||||
Electrostim Medical Services Inc. d/b/a EMSI | Spray | Topical | 10.5 g/100 mL | 2019 | |
Indications
| |||||
Natures Formulae Health Products Ltd. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
Indications
| |||||
Saje Natural Business Inc. | Ointment | Topical | 12.7 mg/1 g | 2016 | |
Indications
| |||||
TriVita, Inc. | Gel | Topical | 8.5 g/100 mL | 2020 | |
Indications
| |||||
Cosmetic Specialty Labs, Inc. | Cream | Topical | 3 g/100 mL | 2022 | |
Indications
| |||||
TRUVITALITY, LLC | Gel | Topical | 4 g/100 g | 2020 | |
Indications
| |||||
Two Old Goats | Lotion | Topical | 1.35 mg/100 mL | 2019 | |
Indications
| |||||
BNG Enterprises DBA Herbal Clean | Gel | Topical | 4.56 g/114 g | 2018 | |
Indications
| |||||
TELEBRANDS CORP | Lotion | Topical | 8 g/100 g | 2022 | |
Indications
| |||||
Pharmaneek, Inc. | Patch | Topical | 200 mg | 2019 | |
Indications
| |||||
Unishield | Lozenge | Oral | 7.6 mg | 2021 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 1.25 g/100 g | 2020 | |
Indications
| |||||
Universal Distribution Center LLC | Gel | Topical | 1.25 g/100 mL | 2020 | |
Indications
| |||||
TARGET CORP | Patch | Topical | 50 mg | 2021 | |
| |||||
Rejuvica LLC | Cream | Topical | 45 mg/1 mL | 2019 | |
Indications
| |||||
McCure Health Solutions Inc. | Gel | Topical | 25 mg/1 g | 2015 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
Indications
| |||||
Xiamen Kang Zhongyuan Biotechnology Co. , Ltd. | Tablet | Topical | 0.45 mg | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
Beijing HKKY Medical Tech. Co. , Ltd. | Aerosol, Spray | Topical | 0.01 g/1 g | 2023 | |
Indications
| |||||
I Shay Cosmetics Inc | Cream | Topical | 1.25 g/100 g | 2021 | |
Indications
| |||||
Walgreen Company | Liquid | Topical | 160 mg/1 mL | 2014 | |
Indications
| |||||
Walgreen Company | Gel | Topical | 2.5 g/100 g | 2014 | |
| |||||
WALGREEN CO. | Gel | Topical | 0.1 g/100 g | 2012 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 5.8 mg | 2025 | |
Indications
| |||||
Walgreens, Co | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Walgreens, Co | Gel | Topical | 40 mg/1 mL | 2018 | |
Indications
| |||||
Walgreen Co. | Cream | Topical | 100 mg/1 g | 2026 | |
Indications
| |||||
Walgreens Company | Patch | Topical | 5 g/100 g | 2022 | |
Indications
| |||||
Walgreens | Aerosol, Spray | Topical | 16 g/100 g | 2023 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | 50 mg/1 g | 2026 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | 50 mg/1 g | 2026 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 7.5 mg | 2025 | |
Indications
| |||||
Walgreens Company | Gel | Topical | 2 g/100 g | 2022 | |
Indications
| |||||
Walgreen Company | Gel | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
Davion, Inc | Powder | Topical | 1 g/100 g | 2018 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 5.4 mg | 2025 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 20 mg | 2025 | |
Indications
| |||||
Walgreens | Lozenge | Oral | 20 mg | 2024 | |
Indications
| |||||
WALGREEN COMPANY | Gel | Topical | 5 mg/1 g | 2017 | |
Indications
| |||||
The Mentholatum Company | Patch | Topical | 50 mg | 2017 | |
Indications
| |||||
I Woke Up Well Distributing Inc | Cream | Topical | 0.03 g/1 g | 2018 | |
Indications
| |||||
WINCO FOODS, LLC | Patch | Topical | 50 mg | 2020 | |
| |||||
WINCO FOODS, LLC | Gel | Topical | 25 mg/1 g | 2026 | |
| |||||
LJ Pharma | Gel | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Foshan Chancheng District Baiyikun Trading Firm | Patch | Topical | 0.14 g | 2024 | |
| |||||
Dynarex Corporation | Gel | Topical | 4 g/100 mL | 2018 | |
Indications
| |||||
Omom Pharmaceuticals, Inc. | Gel | Topical | 1.25 g/100 g | 2017 | |
Indications
| |||||
Cintas Corporation | Lozenge | Oral | 7 mg | 2023 | |
Indications
| |||||
Cintas Corporation | Lozenge | Oral | 9 mg | 2023 | |
Indications
| |||||
Cintas Corporation | Gel | Topical | 100 mg/1 g | 2024 | |
Indications
| |||||
Cintas Corporation | Spray | Topical | 100 mg/1 mL | 2025 | |
Indications
| |||||
China Ningbo Shangge Cosmetic Technology Corp | Gel | Topical | 3 g/227 g | 2014 | |
| |||||
Rejoice International | Gel | Topical | 3 g/227 g | 2014 | |
| |||||
MAXAM | Patch | Topical | 4 g/100 g | 2018 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 1 g/100 g | 2025 | |
| |||||
Wuhan Chinese Moxibustion Technology Development Co. ; Ltd. | Patch | Topical | 10 mg/1000 mg | 2003 | |
| |||||
GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
Indications
| |||||
GUILIN CHINA RESOURCES TIANHE PHARMACEUTICAL CO LTD | Plaster | Transdermal | 35 mg | 2022 | |
Indications
| |||||
KOBAYASHI Healthcare International, Inc. | Spray | Topical | 160 mg/1 g | 2018 | |
Indications
| |||||
KOBAYASHI Healthcare International, Inc. | Gel | Topical | 70 mg/1 g | 2018 | |
Indications
| |||||
KOBAYASHI Healthcare International, Inc. | Liquid | Topical | 160 mg/1 mL | 2018 | |
Indications
| |||||
KOBAYASHI Healthcare International, Inc. | Gel | Topical | 70 mg/1 g | 2018 | |
Indications
| |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Equate Honey Lemon Cough Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Label | Forms | Routes | Menthol | FDA year |
|---|---|---|---|---|
A-S Medication Solutions | Gel | Topical | 40 mg/1 mL | 2012 |
A-S Medication Solutions | Gel | Topical | 50 mg/1 mL | 2016 |
NuCare Pharmaceuticals, Inc. | Gel | Topical | 50 mg/1 mL | 2016 |
A-S Medication Solutions | Gel | Topical | 50 mg/1 mL | 2016 |
A-S Medication Solutions | Gel | Topical | 40 mg/1 mL | 2013 |
DenTek Oral Care, Inc. | Patch, Extended Release | Transmucosal | 2.5 mg/194.85 mg | 2015 |
Rebel Distributors Corp | Gel | Topical | 0.16 g/1 g | 1997 |
Navajo Manufacturing Company Inc. | Powder | Topical | 0.15 g/100 g | 2021 |
SAS Group Inc. | Cream | Topical | 5 1/85 g | 2010 |
A-S Medication Solutions | Lozenge | Oral | 5.8 mg | 2013 |